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ABSTRACT
Continuing and increasing reliance on fossil fuels to satisfy our population’s energy
demands has encouraged the search for renewable carbon-free and carbon-neutral
sources, such as hydrogen gas or CO2 reduction products. Inspired by nature, one
of the objectives of this dissertation was to develop protein-based strategies that
can be applied in the production of green fuels. The first project of this dissertation
aimed at developing a controllable strategy to incorporate domains with different
functions (e. g. catalytic sites, electron transfer modules, light absorbing subunits)
into a single multicomponent system. This was accomplished through the rational
design of 2,2’-bipyridine modified dimeric peptides that allowed their metal-directed
oligomerization by forming tris(bipyridine) complexes, thus resulting in the forma-
tion of a hexameric assembly.
Additionally, two different approaches to incorporate non-natural
organometallic catalysts into protein matrix are discussed. First, cobalt proto-
porphyrin IX was incorporated into cytochrome b562 to produce a water-soluble
proton and CO2 reduction catalyst that is active upon irradiation in the presence
of a photosensitizer. The effect of the porphyrin axial ligands provided by the
protein environment has been investigated by introducing mutations into the native
scaffold, indicating that catalytic activity of proton reduction is dependent on
axial coordination to the porphyrin. It is also shown that effects of the protein
environment are not directly transferred when applied to other reactions, such as
CO2 reduction.
Inspired by the active site of [FeFe]-hydrogenases, the second approach is
based on the stereoselective preparation of a novel amino acid bearing a 1,2-ben-
zenedithiol side chain. This moiety can serve as an anchoring point for the introduc-
tion of metal complexes into protein matrices. By doing so, this strategy enables
i
the study of protein interactions with non-natural cofactors and the effects that it
may have on catalysis. The work developed herein lays a foundation for furthering
the study of the use of proteins as suitable environments for tuning the activity of
organometallic catalysts in aqueous conditions, and interfacing these systems with
other supporting units into supramolecular assemblies.
ii
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CHAPTER 1
PREFACE
As the world population continues to exponentially grow, global energy demand
increases apace. In the World Energy Outlook, the International Energy Agency
projects that the world’s yearly energy demand will rise by 27 %, from nearly
163 PW h in 2017 to 206 PW h by 2040. Almost 75 % of that energy demand
will be met by carbon-based fuels. The use of these fuels has led to currently
unprecedented atmospheric levels of CO2,1,2 a greenhouse gas that has detrimental
effects in the environment, including an increase of Earth’s surface and ocean’s
temperature, melting of ice sheets, and rise of sea levels.2,3 Forecasts indicate that
energy-related CO2 production from human activities will increase to 36 Gt y−1 by
2040,1 thus aggravating these environmental effects. As a response to this problem,
several lines of research aim to discover or improve alternative renewable fuel
production processes.
One of such ideas is to use molecular hydrogen as a fuel source, as this gas
has more chemical energy per mass than liquid fuels (142 MJ kg−1 vs 47 MJ kg−1),
and its sole combustion product is water vapor (Reaction R-1.1).4 However, despite
hydrogen being the most abundant element on Earth, only about 1 % of it can be
found in its molecular form.4 As such, the use of hydrogen gas as combustible is
limited by the methods that are used to produce it.
2H2 (g) + O2 (g) 2H2O(g) (R-1.1)
The majority of hydrogen gas is currently produced by methane steam re-
forming.5 The process consists of a reaction between steam and methane to yield a
mixture of carbon monoxide and hydrogen gas known as syngas. Carbon monoxide
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and steam can later react to form carbon dioxide and hydrogen gas.6 This practice
is energy intensive and relies on the use of fossil fuels, diminishing the environmen-
tal benefits of the use of hydrogen as fuel. Other methods of production involve
the electrolytic splitting of water into its elemental components; however, this feat
requires catalysts such as platinum in order to be carried out efficiently.4,6
Another approach to the production of renewable fuels is to close the car-
bon cycle by taking the CO2 that human activity produces and to reduce it back
into usable fuels, such as methanol, methane, or other higher hydrocarbons. Un-
fortunately, this process currently requires hydrogen gas or high temperatures.7
Additionally, carbon dioxide has a number of reduction products depending on the
number electrons involved in the reaction, availability of protons, reduction poten-
tial, and other reaction conditions (Table 1.1).8
Table 1.1. Standard Reduction Potentials of CO2.8
Reaction E◦′/Va
CO2 + e– CO –2 −1.9
CO2 + 2H+ + 2 e– CO −0.53
CO2 + 2H+ + 2 e– HCO2H −0.61
CO2 + 4H+ + 4 e– C + 2H2O −0.20
CO2 + 4H+ + 4 e– HCHO + H2O −0.48
CO2 + 6H+ + 6 e– CH3OH + H2O −0.38
CO2 + 8H+ + 8 e– CH4 + 2H2O −0.24
a In aqueous solution, pH 7, vs NHE.
To circumvent these limitations, it is necessary to come up with cost-
effective methods that allow the production of hydrogen gas or the selective
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reduction of CO2 into usable fuels. Furthermore, these new methods should not rely
on the use of fossil fuels for them to be environmentally beneficial.
At an average rate of 120 EW at the Earth’s surface, solar power represents
an abundant, accessible, and sustainable source of energy. Nature makes use of
sunlight through photosynthesis, in which energy from light is stored in chemi-
cal bonds at an estimated global rate of 120 TW. However, solar energy is diffuse
(about 100 mW cm−2) and is limited to daylight hours.9 Thus, if solar power is to
be utilized to reduce protons into hydrogen gas, or CO2 into other fuels, it is cru-
cial to develop a system that can not only capture the sunlight, but also efficiently
transform it into the desired products.
Ideally, an optimized catalyst would minimize the energy requirements to
carry out the reactions by providing a suitable environment that stabilizes the
transition state. A large number of organometallic small molecule catalysts have
been prepared and studied over the last decades that can perform proton reduction
and CO2 reduction. Nonetheless, most of these catalysts must operate in organic
solvents, need external acids as proton sources, and often function only at highly
negative electrochemical potentials.
Millions of years of natural evolution have produced an arsenal of catalysts
in the form of enzymes that incorporate organometallic active sites embedded in
a protein matrix. Some of these enzymes, namely hydrogenases, can catalyze the
reduction of protons into molecular hydrogen, whereas other enzymes of interest
are involved in the reduction of CO2, such as carbon monoxide dehydrogenase,
which catalyzes the interconversion between CO2 and CO, or formylmethanofuran
dehydrogenase, which reduces CO2 to formylate methanofuran during an early
stage of methanogenesis. These catalysts operate in aqueous conditions, are finely
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tuned to operate at physiological pH, and have higher turnover numbers than their
small molecule counterparts.
Unfortunately, the direct use of these biological catalysts is not always
straightforward. For instance, the expression of some of these enzymes often re-
quires a complex biosynthetic machinery for their assembly, hampering the ability
to express them recombinantly and resulting in low yields. Additionally, their large
sizes result in low current density, as less molecules can be adsorbed into a surface
at the same time. The presence of labile metal complexes typically requires the
experiments to be carried out under anoxygenic conditions, which demands a phys-
ical separation of the reductive reaction center from their oxidative counterpart.
Finally, the naturally occurring enzymes are only amenable to certain reactions and
to include certain cofactors, limiting their use to such native active sites.
To circumvent these problems, our research group focuses on designing and
evaluating protein-based architectures that are capable of catalyzing these chemical
transformations in mild aqueous conditions while using light as a primary energy
source. This type of reactions can be broken down into three main components:
1) the catalytic site, 2) an electron transfer relay, and 3) the photosensitizer. By
following a modular approach, it is possible to evaluate and optimize each of them
independently, thus the need for a strategy to integrate them together into a single
architecture in order to increase the overall efficiency of the whole system.
This dissertation explores the latter by offering a strategy that can be uti-
lized to control the assembly of the described components into an oligomeric entity
in Chapter 2. The strategy presented herein is based on the rational modification
of a robust dimeric peptide with a 2,2′-bipyridine moiety. By doing so, it is possible
drive their assembly into a hexameric structure (i.e. a trimer of dimers) through
the formation of divalent metal tris(bipyridine) complexes.10
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Further, Chapters 3 and 4 describe the use and development of two differ-
ent strategies for the incorporation of catalysts into protein scaffolds. Particularly,
Chapter 3 details the design of cytochrome b562 mutants that incorporate cobalt
protoporphyrin IX with aims at catalyzing the reduction of protons and CO2 upon
irradiation in the presence of a photosensitizer. More specifically, this work eval-
uated the effects of axial coordinating residues on the activity of the embedded
catalyst in an aqueous environment.
Finally, Chapter 4 focuses on an alternative tool that allows the incorpo-
ration of a variety of organometallic mimics that cannot be found in nature. The
proposed synthetic approach is inspired by the active site of natural enzymes capa-
ble of catalyzing the reversible reduction of protons into hydrogen gas, specifically
[FeFe]-hydrogenases (Reaction R-1.2). This work details the synthesis of an unnat-
ural amino acid, (S)-2-amino-3-(3,4-disulfanylphenyl)propanoic acid, which can act
as a bridging ligand in diiron complexes that are catalytically active toward proton
reduction.
2H+ + 2 e– H2 (R-1.2)
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CHAPTER 2
RATIONAL DESIGN OF A HEXAMERIC PROTEIN ASSEMBLY STABILIZED
BY METAL CHELATION
2.1 Abstract
Protein-based self-assembled nanostructures hold tremendous promise as smart ma-
terials. One strategy to control the assembly of individual protein modules takes ad-
vantage of the directionality and high affinity bonding afforded by metal chelation.
Here, we describe the use of 2,2′-bipyridine units (bpy) as side chains to template
the assembly of large structures (MW approx. 35 000 Da) in a metal-dependent
manner. The structures are trimers of independently folded 3-helix bundles, and
are held together by 2 Me(bpy)3 complexes. The assemblies are stable to thermal
denaturation, and are more than 90 % helical at 90 ◦C. Circular dichroism spec-
troscopy shows that one of the 2 possible [M(bpy)3]2+ enantiomers is favored over
the other. Because of the sequence pliability of the starting peptides, these con-
structs could find use to organize functional groups at controlled positions within a
supramolecular assembly.
2.2 Introduction
The formation of protein-based supramolecular assemblies plays a fundamental
role in biological processes, such as in the structure of the cytoskeleton and intra-
cellular compartments, or support for the life cycle of viruses.1,2 Inspired by this
complex set of functions, protein engineers have sought to generate supramolecular
structures with novel functionalities by learning to control self-assembly and by
exploiting symmetry.3–17
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The use of metal binding motifs offers an attractive methodology to direct
the assembly of smaller subunits into well-ordered systems, with the advantage
of such association being dependent on presence of the metal and independent of
intricate sequence-coded protein-protein interactions.18–26 Further, this strategy
allows the incorporation of metal-mediated functionality such as catalysis, redox
activity, and electron transfer.11,12,27–30 Beyond the metal-ligation properties of
natural amino acids, chelating ligands such as 2,2′-bipyridine (bpy) are very attrac-
tive as means to mediate metal coordination and guide protein assemblies because
they form high-affinity metal complexes with well-defined geometry and symmetry.
Since the first reports using tris(2,2′-bipyridine) metal complexes to template the
formation of three-helix bundles, this functionality has been used extensively as a
structural element to stabilize trimeric entities upon addition of metal cations such
as Fe2+, Co2+, and Ni2+.23,31–36 In a remarkable use of this ligand, by controlling
the identity of the metal ion—thus the kinetics of ligand exchange—it was possible
to select the most stable sequences for three helix bundles via formation of dynamic
libraries.18,37 Incorporating tris(bipyridine)ruthenium(II) directly in homotrimers
has also allowed for simple systems to study electron transfer.38,39 In these systems,
the use of a single solvent-exposed metal binding site at the termini of a peptide
led to multiple backbone conformations, in some cases allowing for the presence of
multiple folds.32
This work makes use of metal chelation by bpy units to template the for-
mation of a “trimer of dimers” assembly formed by nine helices, six of which are
located in the central cavity—henceforth referred to as the “super-core”, and three
of which dock against this central ring (Figure 2.1). The hexamer is highly symmet-
ric, with the central six helices arranged in an antiparallel fashion and displaying
D3 symmetry and containing an additional pseudo 2-fold symmetry axis. At the
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structural level, the assembly is obtained by oligomerization of three-helix bundles,
each formed by a dimer of a helix-loop-helix motif, in which one of the helices is
about half the length of the other. The design is derived from the sequence of Hex-
Phe,40 which was in turn based on the sequence of a Domain Swapped Dimeric
Three Helix Bundle (DSD) that formed hexamers in the crystal structure but not
in solution.41 DSD comprises a leucine-rich hydrophobic core and salt bridges po-
sitioned at the helix-helix interfaces to impart specificity, resulting in remarkable
stability to chemical and thermal denaturation. Exploiting its unusual pseudo 2-
fold symmetry, our group has used DSD as scaffold to generate mimics of ferredoxin
by incorporating pairs of iron-sulfur clusters at controlled distances.27,28,42
Introducing hydrophobic residues in the solvent-exposed side of the long
helices modulates the formation of DSD trimers in a sequence-dependent manner.
Briefly, Hex-Phe utilized aromatic interactions to stabilize the super-core of the
DSD S LAALKSE LQALKKE GFSPEE LAALESE LQALEKK LAALKSK LQALKG
Hex-Phe S LAALKSE LQALKKE GFSPEE LAALESF LQALEKW LAALKSF LQALKG
HB1 S LAALKSE LQALKKE GFSPEE LAALESC LQALEKA LAALKSF LQALKG
HB2 S LAALKSE LQALKKE GFSPEE LAALESC LQALEKA LAALKSA LQALKG
Figure 2.1. Model of the hexameric assembly stabilized by bpy-mediated metal
chelation (top) and sequences of the prepared peptides (bottom).
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Figure 2.2. Reaction between the cysteine side chain and 2-1 to form the bpy
tagged peptides.
α-helical assembly observed in the crystal structure of DSD, resulting in sponta-
neous formation of the hexamer in solution. We speculated that replacement of one
of the aromatic residues per monomer with a bpy unit results in positioning two
sets of trimers at the super-core, at distances compatible with formation of M(bpy)3
complexes. We designed two sequences, HB1 and HB2, differing by the number of
aromatic residues predicted to be in the super-core of the hexamer, each containing
a cysteine residue through which a bpy unit can be linked by nucleophilic substi-
tution of 4-bromo-2,2′-bipyridine (2-1, Figure 2.2). We found that both sequences
formed preferentially stable hexamers over dimers in the presence of divalent tran-
sition metals, and that the magnitude of the effect is dependent on the sequence of
the peptide.
2.3 Materials and Methods
2.3.1 Synthesis of 4-bromomethyl-2,2′-bipyridine
Solvents and reagents were purchased from Sigma-Aldrich. Dry solvents were pur-
chased from Sigma-Aldrich in Sure Seal® bottles. Standard Schlenk techniques
were used for air and moisture sensitive reactions. Diisopropylamine was distilled
over CaH2, and used within 24 h. Pyridine was distilled at atmospheric pressure
over KOH. Nuclear Magnetic Resonance (NMR) data were obtained on a Var-
ian MR400 400 MHz instrument at 25 ◦C and are referenced to the solvent peak
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Scheme 2.1. Synthetic route for 2-1. (a) Tf2O, pyridine, 0 ◦C; (b) i) n-BuLi,
THF, −78 ◦C, ii) ZnCl2, iii) LiCl, 2-3, [Pd(PPh3)4], r. t. to reflux; (c) iPr2NLi,
TMSCl, THF, −78 ◦C; (d) C2Br2F4, CsF, DMF, r. t.
(CDCl3 at 7.26 ppm); all chemical shifts are given in ppm. 4-Bromomethyl-2,2′-
bipyridine (2-1) was prepared in several steps by Negishi coupling as described
before (Scheme 2.1).43
4-Methylpyridin-2-yl trifluoromethanesulfonate (2-3). Under nitro-
gen atmosphere, 2-hydroxy-4-methylpyridine (2-2, 5.0 g, 45.8 mmol) was dissolved
in pyridine (135 mL). The brown solution was cooled to 0 ◦C and trifluoromethane-
sulfonic anhydride (18.6 mL, 110.6 mmol) was added dropwise. After 1.5 hours,
water (50 mL) was added to quench the reaction and dissolve the formed white
precipitate. The solution was extracted with dichloromethane (DCM, 5× 200 mL).
The organic layers were combined, dried over MgSO4, and the solvent evaporated at
reduced pressure to give a dark brown oil. The pure product was obtained by silica
gel column chromatography using hexane/ethyl acetate/triethylamine 89:10:1 as
solvent system to yield a colorless oil (10.5 g, 95 %). 1H NMR (400 MHz, CDCl3): δ
8.24 (d, 1H, J = 5.1 Hz), 7.20 (d, 1H, J = 5.1 Hz), 7.00 (s, 1H), 2.45 (s, 3H).
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4-Methyl-2,2’-bipyridine (2-5). In a three-neck round bottom flask with
a nitrogen inlet and a reflux condenser, 2-bromopyridine (2-4, 1.0 mL, 10.3 mmol)
was dissolved in anhydrous THF (20 mL) under nitrogen. The solution was cooled
down to −78 ◦C and n-butyl lithium (n-BuLi, 1.6 M in hexanes, 11.9 mL, 19.0 mmol)
was added dropwise to give a dark red solution. The mixture was stirred for 30
minutes and was let to warm up to room temperature, at which point ZnCl2 (3.5 g,
25.8 mmol) was added. While the reaction was stirred for 2 hours at room temper-
ature, a solution of [Pd(PPh3)4] was prepared by mixing [Pd2(dba)3] (dba = diben-
zylideneacetone) (259 mg, 0.28 mmol) and triphenylphosphine (0.71 g, 2.71 mmol) in
anhydrous THF (10 mL). After the first reaction was stirred for 2 h, lithium chlo-
ride (0.9 g, 21.0 mmol), 2-3 (2.0 g, 8.33 mmol), and the freshly prepared [Pd(PPh3)4]
solution were added, and the brown-red solution was refluxed overnight under nitro-
gen. A solution of ethylenediaminotetraacetic acid (EDTA, 10 % w/v, 200 mL) was
then added, followed by a saturated solution of NaHCO3 (600 mL). The aqueous
layer was extracted with DCM (3× 200 mL), the organic layers combined, dried
over MgSO4, and the solvent evaporated under reduced pressure. The obtained
brown oil was purified by column chromatography on silica gel using hexane/ethyl
acetate/triethylamine 79:20:1 as eluent, giving the pure product as a yellow oil
that rapidly crystallized as a white solid upon standing (1.36 g, 96 %). 1H NMR
(400 MHz, CDCl3): δ 8.68 (d, 1H, J = 4.6 Hz), 8.54 (d, 1H, J = 5.0 Hz), 8.39 (d, 1
H, J = 7.9 Hz), 8.23 (s, 1H), 7.81 (d, 1H, J = 7.6 Hz), 7.30 (m, 1H), 7.14 (d, 1H,
J = 4.9 Hz), 2.44 (s, 3H).
4-(Trimethylsilyl)methyl-2,2’-bipyridine (2-6). A nitrogen flushed
100 mL round flask was charged with diisopropylamine (2.4 mL, 17.0 mmol) in
dry THF (10 mL). The solution was cooled to −78 ◦C and n-BuLi (1.6 M in hex-
anes, 10.2 mL, 16.3 mmol) is added dropwise. After 10 min, the mixture was slowly
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warmed up to 0 ◦C, stirred for another 10 min, and cooled down again to −78 ◦C. A
solution of 2-5 (2.59 g, 15.2 mmol) in 10 mL of anhydrous THF (10 mL) was then
added dropwise to obtain a thick maroon solution. The resulting mixture was
stirred for 80 min, after which trimethylsilyl chloride (TMSCl, 2.2 mL, 17.3 mmol)
was added, turning the solution blue. The reaction was quenched by a slow ad-
dition of 5 mL of absolute ethanol. The cold reaction was then transferred to a
separatory funnel, washed with a saturated solution of NaHCO3 (40 mL), and the
aqueous layer extracted with DCM (4× 50 mL). The organic fractions were com-
bined, dried over MgSO4, and evaporated under reduced pressure to obtain an
orange oil. The crude product was purified by column chromatography in silica gel
using hexanes/ethyl acetate/triethylamine 89:10:1 as mobile phase to give a col-
orless oil (1.62 g, 44 %). 1H NMR (400 MHz, CDCl3): δ 8.68 (m, 1H), 8.47 (d, 1H,
J = 5.0 Hz), 8.38 (d, 1H, J = 8.0 Hz), 8.06 (s, 1H), 7.80 (td, 1H, J = 1.8, 7.8 Hz),
7.29 (m, 1H), 6.95 (dd, 1H, J = 1.6, 5.0 Hz), 2.22 (s, 2H), 0.04 (s, 9H).
4-Bromomethyl-2,2’-bipyridine (2-1). In a 100 mL round bottom flask
under nitrogen atmosphere in the dark, cesium fluoride (0.91 g, 5.99 mmol) and
1,2-dibromotetrafluoroethane (1.54 g, 5.93 mmol) were added to a solution of 2-6
(0.70 g, 2.89 mmol) in anhydrous N,N -dimethylformamide (DMF, 25 mL). The re-
action was stirred at room temperature overnight to obtain an orange solution.
The reaction was washed with water (150 mL) and extracted with ethyl acetate
(3× 100 mL). The organic layers were combined, washed with brine (100 mL),
dried over MgSO4, and the solvent is removed under reduced pressure. The crude
brown oil is purified by silica gel column chromatography using hexane/ethyl ac-
etate/triethylamine 79:20:1 to give a colorless oil (0.65 g, 90 %). 1H NMR (400 MHz,
CDCl3): δ 8.71 (m, 1H), 8.67 (d, 1H, J = 5.0 Hz), 8.42 (m, 2H), 7.84 (m, 1H),
7.34 (m, 2H), 4.49 (s, 2H).
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2.3.2 Peptide Synthesis and Purification
All peptides were synthesized by automated microwave-assisted Solid Phase Peptide
Synthesis (SPPS) on a Liberty instrument (CEM Corporation). The synthesis was
carried out using standard Fmoc protection procedures. Briefly, Rink Amide resin
was deprotected using 0.1 M 1-hydroxybenzotriazole (HOBt) in a 20 % v/v piperi-
dine in DMF solution. Amino acid couplings were achieved using 0.45 M N,N,N ′,N ′-
tetramethyl-O-(1H -benzotriazol-1-yl)uronium hexafluorophosphate (HBTU) in
DMF, 2 M N -ethyl-N -(propan-2-yl)propan-2-amine (DIEA) in N -methyl-2-pyrrolidi-
none (NMP), and 0.2 M fluorenylmethyloxycarbonyl (Fmoc) protected amino acid
(Novabiochem), followed by microwave irradiation to pre-established temperatures
according to CEM protocols. Peptides were acetylated at the N -terminus via addi-
tion of acetic anhydride under coupling conditions. The peptides were cleaved from
the resin using 94 % trifluoroacetic acid (TFA), 2.5 % water, 2.5 % 1,2-ethanedithiol
(EDT), and 1 % triisopropylsilane (TIS) for 3 h. The solution was then evaporated
under a stream of N2, and the peptide was precipitated with cold ether. Crude,
lyophilized peptides were purified using preparatory-scale HPLC on a C18 reverse-
phase column, with a linear gradient of Solvent A (99.9 % water with 0.1 % TFA)
and Solvent B (95 % acetonitrile, 4.9 % water, and 0.1 % TFA) at a flow rate of
10 mL min−1. Peptide identity was confirmed by MALDI-TOF-MS; peptides were
>99 % pure as assessed by C18 analytical Reverse Phase High-Performance Liquid
Chromatography (RP-HPLC).
2.3.3 Conjugation
The synthesized peptide (7.0 mg, 1.4 µmol) was dissolved in guanidinium hydrochlo-
ride (Gdn·HCl, 6 M)/2-amino-2-(hydroxymethyl)propane-1,3-diol (Tris, 100 mM)
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buffer at pH 9.6. A solution of tris(2-carboxyethyl)phosphine hydrochloride
(TCEP·HCl, 20.8 mg, 73µmol) in this same buffer (2 mL) was added, and the
mixture was heated to 70 ◦C for 30 min. A solution of 2-1 (23.6 mg, 95 µmol) in
buffer/acetone (4:1 by volume) was added and the reaction was stirred at 70 ◦C
overnight. The peptide was then purified by preparative RP-HPLC as described
above.
2.3.4 Metal Incorporation and Quantification
Divalent metal ions were incorporated into peptide variants by adding an excess
amount (20 eq) of the metal chloride salt (CoCl2·6H2O or NiCl2·6H2O, respec-
tively) in Gdn·HCl (6 M)/ Tris (100 mM) buffer at pH 7.5. The mixture was in-
cubated overnight at 4 ◦C. The resulting dark brown solution was subjected to
desalting with a PD10 G25 column (GE Healthcare) that was pre-equilibrated with
100 mM Tris at pH 7.5 to obtain the holo protein.
2.3.5 Gel Filtration
Size exclusion chromatography was performed on a G-25 gel filtration column fit to
an Agilent Technologies 1260 Insight Fast Protein Liquid Chromatography (FPLC)
system. The column was pre-equilibrated in 100 mM Tris pH 7.5, and 200 µL of
150µM apo or holo peptide were used for each injection.
2.3.6 Analytical Ultracentrifugation
Sedimentation velocity experiments were carried out with a Beckman Coulter
XL-I instrument equipped with a monochromator and interference scanning op-
tics (632 nm) using a Ti-50 rotor as described before.44 Briefly, analytical ultracen-
trifugation cells were loaded with 420 µL of the samples at starting concentration
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of approximately ∼100 µM and allowed to equilibrate for 2 h at 4 ◦C. The buffers
used in the measurements contained 10 mM 2-amino-2-(hydroxymethyl)propane-
1,3-diol hydrochloride (Tris·HCl) pH 8.5 and 479 µM CoCl2 or NiCl2, where rele-
vant. The samples were spun at 40 000 rpm (115 000g) and absorbance scans were
taken continuously at 298 nm (Co-HB1 and Ni-HB1), 290 nm (Hex-Phe), or 286 nm
(HB1 and HB2), respectively, with a 0.003 cm step size, until the last of the bound-
aries had moved to the bottom of the solution column (at least 12 h). Data was
reduced using Sedfit44 using calculated values for buffer viscosity and density from
SEDNTERP. C(s) analysis was used to determine relative amounts and sizes of
species observed.
Sedimentation equilibrium experiments were carried out with a Beckman
XL-I and Ti-50 rotor at 4 ◦C. Briefly, samples (110µL) containing varied concen-
trations of sample (0.1–0.8 mg mL−1) were loaded into 3 chambers of a 6-chamber
centerpiece, with buffer in each of the remaining 3. The samples were then sub-
jected to centrifugal speeds of 14 000, 20 000, and 26 000 rpm for a period of 72–96 h.
Equilibrium was established when a reasonable (<0.07) and constant rmsd was
found between sequential scans 4 hours apart. High resolution scans were taken at
various wavelengths (280, 282, and 298 nm), with a radial step size of 0.001 cm. The
data were analyzed using global fitting in Sedfit with a single species. Buffer den-
sity was calculated from SEDNTERP and partial specific volumes were determined
from the sequence.
2.3.7 Circular Dichroism Spectroscopy
Spectra were recorded on a JASCO J-815 spectropolarimeter in the range of 190–
260 nm or 300–400 nm. Data were recorded every 1 nm and averaged over 3 scans.
The concentration of apo and holo-peptides was kept at 50µM in 100 mM Tris,
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pH 7.5. Chemical denaturation titrations were carried out through addition of an
8 M stock solution of Gdn·HCl, followed by mixing and incubation for 5 min to
allow for equilibration. Holo peptide was titrated under anaerobic conditions. Spec-
tra were normalized to protein concentration in the sample and converted to frac-
tion folded relative to the apo or holo protein signal, which lacked Gdn·HCl.
2.4 Results and Discussion
2.4.1 Protein design and synthesis
Starting with the crystal structure of DSD (PDB ID 1G6U), we chose position 28,
which is found in the super-core, for attachment of a bpy moiety via conjugation
to a cysteine residue. The octahedral metal-chelated [M(bpy)3]2+ complex can exist
as two enantiomers, the ∆ and Λ, with coordinates available from the Cambridge
Structural Database (CSD ID Co2+: BPCOFC10, Ni2+: ADOCOM).45 Each com-
plex was modeled in Pymol and functionalized with a methyl group in position
4, which will provide the chemical moiety for conjugation to the thiol moiety of
cysteine upon nucleophilic attack. We manually docked each pre-formed complex
within the super-core within the chosen layer. We then explored the possible ro-
tamers of Cys28 in helical conformation to identify the ones that placed the thiol
at a distance compatible with ligation to the methyl group. We found that the ∆
enantiomer was a better fit for the super-core. Because of the D3 pseudosymmetry
of the assembly, this operation results in the creation of two metal binding sites in
the super-core (Figure 2.1). To explore the interplay between aromatic interactions
and metal chelation in forming a stable assembly, two versions of the peptide were
designed. Compared to Hex-Phe, HB1 conserves a phenylalanine residue at position
18
42 while HB2 contains an alanine at that position. The remaining position at the
super-core, 35, was also mutated to alanine to relieve steric clashes.
Peptides corresponding to HB1 and HB2 were readily synthesized uti-
lizing microwave-assisted solid phase peptide synthesis followed by purification
via reverse-phase HPLC purification on a C18 analytical and semi-prep column.
4-Bromomethyl-2,2′-bipyridine (2-1)was synthesized via Negishi cross-coupling
following published protocols.43 Coupling of 4-bromomethyl-2,2′-bipyridine to
cysteine 28 of each peptide was carried out overnight at 70 ◦C in highly denatur-
ing conditions (6 M Gdn·HCl) to ensure peptide unfolding, under argon and
in buffered reducing conditions. The products, HB1 and HB2, were purified by
reverse-phase HPLC and verified by MALDI-TOF-MS (Figure A.1).
2.4.2 Protein characterization and metal binding
The incorporation of bipyridine moieties is also verified by the presence in the
Ultraviolet-Visible spectroscopy (UV-Vis) spectra of apo HB1 and HB2 of absorp-
tion bands corresponding to the intraligand pi → pi∗ transition at 244 and 286 nm
characteristic of bipyridine, which overlaps with the aromatic residues (Figures 2.3
and A.2). When the peptides were reconstituted with Ni2+ and Co2+, the pi → pi∗
absorption bands underwent a characteristic red shift to 298 nm (Ni2+) and 297 nm
(Co2+), respectively, with shoulders visible at 307 nm.46 A binding stoichiometry
of 2.8 and 3.4 peptides per metal respectively was obtained by titrating CoCl2
and NiCl2 into of HB2 (Figure 2.4), and of 3.4 and 3.5 into HB1 (Figure A.3). No
changes were observed in titrating Hex-Phe, used as control, with Ni2+ and Co2+,
indicating that other amino acids on the peptide scaffold do not interact with diva-
lent metals (Figures A.7 and A.8).
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Both peptides fold into structures with high helical content in solution, as
indicated by the two peaks at 208 and 222 nm in the far-UV Circular Dichroism
spectroscopy (CD) data, typical of α-helical peptides (Figures 2.5 and A.4), sug-
gesting that incorporation of the bipyridine ligand into the peptide structure did
not affect the overall structure relative to the parent peptides DSD and Hex-Phe.
Reconstitution of HB1 and HB2 with Ni2+ and Co2+ results in preservation of the
α-helical content, indicating that the structure of the peptides was maintained. In
the case of NiHB2, however, the CD spectrum shows a variation of the ratio of the
CD signal at 208 and 222 nm, which is typically close to one in highly symmetric
and well-ordered helical systems (Figure 2.5). To further investigate the stability of
the metal-chelated assemblies, we monitored helical content as a function of temper-
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Figure 2.3. UV-Vis traces for the titration of HB2 (black trace) with CoCl2 (top)
or NiCl2 (bottom; blue traces).
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Figure 2.4. Binding curves of HB2 titrated with CoCl2 (left) and NiCl2 (right) as
monitored by UV-Vis. The calculated binding stoichiometry was (a) 2.8 peptides
per metal ion, (b) 3.4 peptides per metal ion.
ature. In keeping with the parent peptides, determination of melting temperature
(Tm) is not possible because of the high stability of the assemblies to thermal de-
naturation (Figure A.5).40,41 However, HB2 reconstituted in the presence of the
metals is less stable than the apo peptides, despite a higher content in hexameric
structures (see section 2.4.3). In particular, we observed higher loss of secondary
structure for the Ni-bound HB1 and HB2, suggesting that these complexes are less
compatible with the super-core than the cobalt ones. One possible reason is that
nickel(II) forms much stronger complexes with bpy than cobalt(II), resulting in dis-
tortion to the helical structure in the hexameric assembly.46,47 Bpy has the ability
of forming chiral metal complexes, namely the ∆ and the Λ enantiomers, which give
rise to characteristic dichroic signals in the near-UV region, corresponding to the
pi → pi∗ transitions. In solution, neither of the two forms is favored, resulting in
net dichroic signal of zero (Figure A.6). In contrast, both the Ni2+ and Co2+ com-
plexes of HB2 display a CD signature in the 290–330 nm range, with peaks at 304
and 311 nm (Ni2+), and 306 and 313 nm (Co2+), consistent with the ∆ isomer.46
The presence of a net dichroic signal indicates that formation of one enantiomer
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Figure 2.5. CD spectra (left) and CD signal (right) corresponding to the bpy
absorption of HB2 (red), CoHB2 (blue), and NiHB2 (green).
is preferred over the other, possibly because it is energetically favored when incor-
porated within the super-core. The emergence of a dichroic signal was previously
observed in constructs that utilized tris(bpy) complexes to template a three-helix
bundle,32 or a trimeric assembly.23 Interestingly, the Λ enantiomer was favored in
those designs.
2.4.3 Metal-mediated oligomerization
We utilized Analytical Ultracentrifugation (AUC) to assess the association state
of the apo- and metal-reconstituted peptides in solution. The results of sedimenta-
tion velocity experiments are summarized in Figure 2.6. The bpy-modified peptides
behave similarly to their non-modified counterparts:40,41 the HB1 peptide formed
hexamers when loaded at high peptide concentrations, while favoring dimers at
lower peptide concentrations. Conversely, HB2 is predominantly dimeric in solution,
with a small percent forming larger hexameric structures. In both cases, chemical
modification with the bipyridyl moiety shifts the equilibrium towards the hexameric
form compared to the parent peptides. As predicted, reconstitution with a divalent
metal further shifts the equilibrium towards the hexamer, reflecting the formation
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Figure 2.6. Oligomerization state of the peptides in presence and absence of diva-
lent metals (blue, dimer; orange, hexamer).
of the complex. Addition of Co2+ results in formation of 83 % and 100 % hexamer
for CoHB2 and CoHB1 respectively. Following suit, addition of Ni2+ to HB2 in-
creases hexamer formation to 95 % total. In stark contrast, the addition of Ni2+
to HB1 decreases hexamer fraction to only 47 % of total, 17 % less than metal free
peptide. Control experiments were carried out to assess the effect of divalent metals
on the oligomerization state of Hex-Phe by sedimentation ultracentrifugation. No
significant changes to the sedimentation profile were observed, indicating that the
species are identical (Figure A.9).
2.5 Conclusion
We have shown that metal chelation, mediated by the incorporation of bipyridyl
moieties into the solvent exposed surface of a three-helix bundle, stabilizes the for-
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mation of trimers and results in the formation of stable supramolecular assemblies.
Compared to natural amino acids, the bpy ligand contains two pyridyl nitrogen
atoms in orientation compatible with metal chelation, thus forming complexes with
higher energies of formation and, in the trimer form, octahedral geometry. Mod-
eling suggested that this geometry is compatible with the hexameric assembly ob-
served in the crystal structure of DSD (1G6U).41 We found that addition of nickel
or cobalt resulted in shifting the dimer-hexamer equilibrium to the hexamer in a
sequence dependent manner, while preserving the helical structure of the peptides.
Because of the unique symmetry of the assembly, this design is unique in allowing
for further functionalization. For example, we have previously inserted two iron-
sulfur clusters at controlled distances in the DSD scaffold, and demonstrated that
the redox potentials can be modulated with single-point mutations.27,28,42 Our cur-
rent results suggest that metal chelation could be used to organize redox-active
moieties in a spatially controlled manner, utilizing self-assembly of the DSD scaf-
fold in closed hexamers. Further, this strategy may be used to stabilize fibrillar
assemblies observed in DSD mutants.41
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CHAPTER 3
EVALUATION OF THE CATALYTIC ACTIVITY OF COBALT CYTOCHROME
B562 TOWARD CO2 REDUCTION IN WATER
3.1 Introduction
The ongoing use of fossil fuels has led to an increase in atmospheric CO2 concen-
trations, causing severe consequences for the environment.1 As a response to this,
current research efforts are focused on developing energetic alternatives that can
help curb CO2 emissions. Although nature aids in the removal some of this green-
house gas through photosynthesis,2,3 negative emissions technologies are necessary
to reduce the excess gas from the atmosphere.4
One path to do so is through artificial photosynthesis, where light is uti-
lized as the energy source to drive the chemical transformation of CO2 into usable
chemicals such as fuels. Nonetheless, selectivity between the product of water reduc-
tion (namely H2 gas) and the variety of products that can be obtained from CO2
(Table 1.1) poses a problem when reducing CO2 in aqueous conditions.5
Artificial metalloenzymes can potentially be used as selective catalysts
for this reaction by offering an optimized environment not only to minimize the
energy landscape of the rate limiting step, but also to provide channels for reac-
tant binding and product release to and from the active site while protecting the
organometallic center from degradation.6,7
Our group and others have demonstrated increased catalytic lifetime and
overall turnover number of well-characterized H2 production catalysts, both in wa-
ter and in mild conditions. Recent work with nickel cyclam complexes has shown
that catalytic CO2 reduction can be enhanced by incorporation into the protein ma-
trix, and that product selectivity can be controlled by the protein environment.8,9
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Additionally, our group has shown that exchange of the metal ion to cobalt in
heme-binding proteins or peptides results in an increase of H2 production compared
to the porphyrin in solution. Moreover, altering the protein sequence results in fine
modulation of the total activity, further supporting the crucial role of the protein
environment throughout the catalytic cycle.10–12
The use of metalloporphyrins as molecular CO2 reduction electrocatalysts
has been extensively explored in the recent years.13–17 Remarkably, modifications
of reaction conditions or the porphyrin framework, particularly those that are able
to directly participate in the reaction (such as by stabilizing catalytic intermedi-
ates through hydrogen bonding) have shown increased activities of these catalysts
toward CO2 reduction.18–23 Further, the higher turnover numbers and the product
selectivity upon incorporation of cobalt porphyrins into supramolecular structures
such as metal-organic frameworks24–26 and polymers27 suggest that catalysis by
these metal complexes could be enhanced by binding to a protein environment.
This chapter describes the reengineering of cytochrome b562 (cyt b562) into
water-soluble catalysts capable of reducing CO2 in aqueous conditions. Cyt b562 is
a small, water-soluble, four-helix bundle that natively binds a heme cofactor via
bis-axial ligation from the side chains of residues His102 and Met7 (Figure 3.1). In
previous work, our group probed the effect of mutating the coordinating methionine
to alanine, aspartate, or glutamate in hydrogen production, showing an increase in
hydrogen production of the mutant M7A over wild type (WT).12 This project ex-
pands this investigation by analyzing the effect of axial mutations on the efficiency
of CO2 reduction in water, which yields formate, carbon monoxide, and hydrogen
upon light irradiation conditions by making use of a photosensitizer and a sacrifi-
cial electron donor. The generated mutants were designed to either remove axial
ligation sites (M7A and H102A) or alter axial ligation (M7H) in order to probe the
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(a) (b)
Figure 3.1. Structure of cyt b562 showing the coordinating axial ligands. PDB
entry: 1QPU. Colors represent carbon (porphyrin: black, axial residues: orange),
oxygen (red), nitrogen (blue), sulfur (yellow). The metal ion is shown as a sphere
(brown).
electronic and steric effects that these ligands (or lack thereof) may have during
catalysis.
3.2 Materials and Methods
All chemicals were purchased from Sigma-Aldrich and used without further purifi-
cation unless otherwise noted. Calibration gases were obtained from Matheson in
14 L lecture bottles. All aqueous solutions were prepared using deionized water with
a resistivity greater or equal to 18 MΩ. Cobalt(III) protoporphyrin IX chloride was
purchased from Sigma-Aldrich and used without further purification.
3.2.1 Protein Expression
Mutants were generated using Gibson assembly and sequenced directly in the
pET30c(+) vector utilizing the T7 promoter sequence. The verified mutants were
transformed into a BL21(DE3) E. coli cell line and grown in 1 L of 2xTY media
at 37 ◦C with shaking. Cells were induced with 1 mM β-d-thiogalactopyranoside
(IPTG) at an OD600 of 0.6 and cells were harvested after 4 h of expression. The
cell pellets were suspended in 20 mM Tris·HCl, 1 mM dithiotreitol (DTT), 0.5 mM
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EDTA and lysed by multiple cycles of ultrasonication. The clarified lysate was
brought to 75 % saturation with solid ammonium sulfate, and precipitated proteins
were removed by centrifugation. The supernatant, containing the cytochrome mu-
tants, was dialyzed against two changes of 10 mM Tris pH 7.5 and one of water at
4 ◦C.
Following dialysis, the protein solution was lyophilized and redissolved in
10 mM NaCl for further purification via RP-HPLC using a preparatory scale C18
column with a linear gradient from 100 % solvent A (0.1 % v/v TFA in water) to
100 % solvent B (4.9 % v/v water, 0.1 % v/v TFA in acetonitrile). The fractions
containing the desired protein were then lyophilized to yield the pure apo-protein.
The protein identities were confirmed via MALDI-TOF-MS and their purity deter-
mined by C18 analytical analysis.
Purified proteins were reconstituted with cobalt protoporphyrin IX
(CoPPIX) similarly to previously reported procedures. Samples in 100 mM Tris
pH 8.5 were subjected to 50 M excess of DTT for 30 min, followed by a 50 M excess
of CoPPIX for 1 h. Excess porphyrin was removed by subjecting protein to a PD10
desalting column equilibrated in 50 mM Tris pH 7.5. Sample concentrations were
determined via UV-Vis utilizing extinction coefficients determined by Inductively
Coupled Plasma-Optical Emission Spectroscopy (ICP-OES), normalizing spectrum
to the measured cobalt concentration. The protein was used immediately or frozen
at −80 ◦C for future characterization.
3.2.2 Binding Assays
The dissociation constants (Kd) for each of the mutants was estimated by titrating
a solution of CoPPIX in 1 M potassium phosphate (KPi) pH 6.0 with a solution of
the appropriate protein containing the same total concentration of CoPPIX and
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monitoring the change in absorbance of the Soret band of the free or bound por-
phyrin (417 nm or ca. 425 nm, respectively).
Since both Soret peaks overlap with each other, we can write the absorbance
at a particular wavelength λ as:
Aλ = ελCo[Co] + ελCoP[CoP] (3.1)
Further, when no protein has been added, equation 3.1 becomes:
Aλ0 = ελCo[Co]T (3.2)
where [Co]T corresponds to the total CoPPIX concentration. Subtracting equa-
tion 3.1 from equation 3.2 and simplifying we obtain:
∆Aλ = Aλ0 − Aλ = ελCo ([Co]T − [Co])− ελCoP[CoP] (3.3)
For the dissociation equilibrium of CoP shown in reaction R-3.1, we can
write the mass balance equation for CoPPIX as equation 3.4.
CoP Co + P (R-3.1)
[Co]T = [Co] + [CoP] (3.4)
By using equation 3.4, equation 3.3 becomes:
∆Aλ = ∆ελ[CoP] (3.5)
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where ∆ελ = ελCo − ελCoP. The Kd expression for the dissociation of CoP is given by
equation 3.6, and the mass balance equation for protein is shown in equation 3.7.
Kd =
[Co][P]
[CoP] (3.6)
[P]T = [P] + [CoP] (3.7)
Making use of mass balance equations 3.4 and 3.7, substituting equation 3.5 appro-
priately, and solving for [P]T we can modify equation 3.6 to obtain:
[P]T =
Kd ·∆Aλ
∆ελ[Co]T −∆Aλ +
∆Aλ
∆ελ (3.8)
which can be used to fit our data, albeit in the less conventional way of having ∆Aλ
as the independent variable, rather than [P]T.
3.2.3 Circular Dichroism Spectroscopy (CD)
CD spectra were recorded on a JASCO J-815 spectropolarimeter in the range of
190–260 nm. Data points were recorded every 1 nm and averaged over 3 scans. The
concentrations of apo and holo-proteins were kept at 10µM in 10 mM Tris pH 7.5.
Thermal denaturation was performed by heating samples from 4 to 90 ◦C, monitor-
ing loss of signal at 222 nm.
3.2.4 Photocatalysis Experiments
The stock buffer was prepared by making a solution containing 200 mM KPi and
125 mM ascorbic acid (AscOH) and adjusting it to pH 6.0. The solution was then
bubbled with CO2 or Ar, and adjusted back to pH 6.0 with KOH if necessary. Fi-
nally, solid [Ru(bpy)3]Cl2·6H2O was added to make a 1.25 mM solution, and the
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buffer aliquoted out, the headspace evacuated with the appropriate gas, and the
aliquots flash frozen and stored at −80 ◦C. Before each assay, CoPPIX was dis-
solved in 100 mM KOH to make a saturated solution, and the concentration is de-
termined by UV-Vis using the Soret peak at 417 nm with an extinction coefficient
of ε = 143 540 M−1 cm−1 (as determined by ICP-OES measurements). The frozen
buffer is thawed under an atmosphere of the corresponding gas, and an appropriate
amount of CoPPIX and/or protein (in 200 mM KPi) is added to obtain a work-
ing solution containing 20 µM CoPPIX, 30 µM protein, 100 mM AscOH, and 1 mM
[Ru(bpy)3]2+ in 200 mM KPi.
For each trial, 400µL of the prepared sample was added to a 10 mm× 1 mm
gas tight cuvette of known headspace volume, and the headspace sparged with the
appropriate gas (Ar or CO2) for 20 min. The cuvettes were then irradiated with a
white light LED source for 8 h. The gaseous products, H2 and CO, were analyzed
at different time intervals using gas chromatography, while formate was quantified
at the end of the experiment using 1H NMR as detailed in the next section. All
experiments were done in triplicate and the variation is reported as the standard
deviation of the sample.
3.2.5 Product Quantification
At the appropriate time intervals, the headspace was sampled with a gas-tight sy-
ringe for H2 and CO quantification by first injecting the same volume of Ar or CO2
to be withdrawn, mixing thoroughly, and removing the corresponding sample.
The samples were analyzed in an SRI Instruments gas chromatograph
equipped with a 3 ′ × 1/8 ′′ molecular sieve 5Å packed column with a Thermal
Conductivity Detector (TCD) and a Flame Ionization Detector (FID) with a
methanizer connected in series. The analytes are eluted using Ar as a carrier gas
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with a temperature program starting at 60 ◦C for 1 min, ramping at 20 ◦C min−1
until 80 ◦C, holding for 2 min, ramping at 50 ◦C min−1 to 250 ◦C, and holding until
the CO2 exits the instrument, with a retention time (tR) ca. 12 min. A peak cor-
responding to H2 was seen on the TCD channel at tR = 0.400 min, while the peak
corresponding to CO appeared at tR = 3.42 min on the FID channel. By comparing
the peak areas to a calibration curve, we are able to quantify the number of moles
of each gas in the injected sample.
After irradiation was stopped, the solution was frozen at −80 ◦C for future
analysis. Formate was quantified by diluting the sample to make a solution con-
taining 10 % v/v D2O in water and 100µM sodium 4,4-dimethyl-1-silapentane-1-
sulfonate (DSS) as an internal standard. The samples were then analyzed by 1H
NMR using a water suppression method with 64 scans and a 30 s relaxation delay.
The formate concentration was determined by comparing the integration area of the
singlet at 8.45 ppm to the DSS peak at 0.0 ppm.
3.3 Results and Discussion
3.3.1 Protein Expression and Characterization
All apo proteins were obtained as described in section 3.2 with the analytical HPLC
traces showing >95 % purity of the protein. The CD characterization of WT and
M7A has been previously reported by our group.12 The apo M7H and H102A mu-
tants were also characterized by CD where they showed the typical signals of α-
helical proteins, with local minima at 208 and 222 nm (Figures B.5 and B.6). Fur-
ther, the signal intensity increases upon addition of CoPPIX indicating an increase
in helical content upon binding of the cofactor. This gain in stability was corrobo-
rated by following the loss of intensity of the 222 nm peak with increasing temper-
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ature to obtain the thermal denaturation curves (Figures B.5 and B.6). Table 3.1
shows that the Tm for all of the mutants increases with addition of CoPPIX, fur-
ther indicating an increase in stability of the fold upon reconstitution with their
cofactor.12
Table 3.1. CD characterization data of apo and holo cyt b562 mutants.
Mutant Tm (apo) / ◦C Tm (holo) / ◦C ∆Tm / ◦C
WTa 58 85 +21
M7Aa 52 64 +12
M7H 47 62 +15
H102A 56 61 +5
a From reference 12.
Binding of the cofactor was also analyzed through UV-Vis titration of apo
protein to a solution of CoPPIX. In all cases the Soret peak showed a bathochromic
shift, with a λmax = 230 nm for WT and 425 nm for the mutants (Figures B.1
to B.4). The ∆ε (at 430 nm for WT to minimize signal overlap, 417 nm for the
mutants) and Kd values for each titration were obtained by fitting the data to equa-
tion 3.8 (Figures B.1 to B.4) and are summarized in Table 3.2. The ∆ε values cor-
responded to the those calculated from the last points on each of the titrations
(2–5 eq) within 5 % error. All the obtained Kd values were on the low nanomolar
range, indicating that all mutants bind CoPPIX with similar affinity, thus sug-
gesting that binding is driven mainly by the hydrophobic sequestration of the por-
phyrin rather than by binding of the axial ligands.
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Table 3.2. Binding data of CoPPIX-cyt b562 mutants as monitored by UV-Vis.
Mutant
∆ε417/
Kd / nM Adj. R2
mM−1 cm−1
WT 78.47 a 217± 30 0.9743
M7A 98.21 170± 7 0.9814
M7H 101.64 126± 42 0.8825
H102A 116.30 28± 17 0.8678
a At 430 nm.
3.3.2 Photocatalytic Activity
The cyt b562 mutants were assayed to investigate their ability to reduce CO2 under
photoinduced conditions by using [Ru(bpy)3]2+ as photosensitizer and ascorbic acid
as sacrificial electron donor in water. Upon irradiation [Ru(bpy)3]2+ achieves an
excited state that can be reduced by ascorbic acid into [Ru(bpy)3]+, which can then
transfer electrons to the catalyst for the reduction of substrate (Figure 3.2, steps
1–3).28
Under the studied experimental conditions, the catalysts were capable of
reducing protons into H2 both in the presence and absence of CO2 as substrate.
Further, carbon monoxide and formate were also observed as products when CO2
was present. Controls lacking CoPPIX showed little H2 was produced and no CO
or HCO –2 were detected, indicating that these species were indeed produced by
the cobalt catalyst. The presence of each of these products can be explained on
the basis of previous mechanistic studies of cobalt porphyrins used as catalysts
for these reactions (Figure 3.2). Briefly, the metal site is reduced to Co(I) by the
photosensitizer as described above (step 3), which is capable of binding H+ to form
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Figure 3.2. Catalytic cycles for the generation of H2, CO, and HCO –2 by cobalt
porphyrins through photoirradiation in the presence of [Ru(bpy)3]2+ and ascorbic
acid as sacrificial electron donor. Based on references 28 and 33.
a metal hydride complex (step 4), or CO2 to form the corresponding adduct (step
8). The metal hydride complex can then be protonated to form H2 gas (step 5),
or it can undergo an insertion reaction with CO2 to form formate (steps 6 and 7);
while the CO2 adduct can proceed through a series of proton transfer events that
culminate in the loss of water and formation of CO (steps 9 and 10).28–32
Not surprisingly, experiments that lacked the protein scaffold in solution
soon showed a precipitate in the cuvettes. This is consistent with the fact that
CoPPIX forms insoluble aggregates in water. The trials that included any of the
cyt b562 mutants did not show any discernable precipitate throughout the length of
the experiment.
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The activity of the catalyst was followed over time and is reported as the
turnover number (TON) of each catalyst, defined as the total number of moles of
product produced during the experiment divided by the initial number of moles
of catalyst (8 nmol). The catalysts were initially evaluated under 1 atm CO2 in a
buffer saturated with this gas at pH 6.0 (Figures 3.3 and 3.4). Figure 3.5 summa-
rizes the final TON for the catalysts in the assayed conditions (8 nmol). Interest-
ingly, all mutants showed similar activity for CO production (TON ∼35), albeit
still higher than that observed for the porphyrin alone (TON 19± 1), indicating
that activity is increased by the interaction of the protein with the porphyrin. Sur-
prisingly, formate concentrations where similar in the experiments with free por-
phyrin and for all of the mutants with the exception of M7A, which showed slightly
lower formate concentrations (TON ∼35 vs. 20± 3). Nonetheless, the mutants did
show variation in their H2 production activity at pH 6.0 (Figure 3.3): M7A showed
a (20± 5) % increase in H2 compared to the porphyrin alone, followed by M7H
((45± 7) %), then WT ((72± 7) %), and finally H102A with the highest increase in
activity ((113± 5) %).
To determine if there was any net effect of the presence of CO2 on the re-
duction of protons, the catalysts’ activity was assayed under the same conditions
without CO2 by sparging the solution and headspace with Ar instead (Figure B.9).
As expected, no CO or HCO –2 were detected, which is consistent with the fact that
these compounds are indeed the product of CO2 reduction in the previous experi-
ments. As shown in Figure 3.5, the TON values for H2 for CoPPIX and the cyt b562
mutants remained the same, indicating that overall H2 production is not affected by
the presence of CO2.
These results indicate that the activity trends observed for H2 production
are independent of the presence of CO2. This suggests that axial ligation at posi-
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Figure 3.3. Produced H2 over time from the photoinduced reduction of protons
by [Ru(bpy)3]2+, CoPPIX, and cobalt cyt b562 mutants at pH 6.0 under 1 atm CO2.
The experiments were carried out in 100 mM AscOH, 1 mM [Ru(bpy)3]2+, 200 mM
KPi, and 20 µM catalyst (when appropriate). The error bars represent the standard
deviation of the sample.
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Figure 3.4. Produced CO over time from the photoinduced reduction of protons
by CoPPIX and cobalt cyt b562 mutants at pH 6.0 under 1 atm CO2. The experi-
ments were carried out in 100 mM AscOH, 1 mM [Ru(bpy)3]2+, 200 mM KPi, and
20 µM catalyst. The error bars represent the standard deviation of the sample.
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tion 7 results in the highest activity, thus explaining why M7A, which lacks coor-
dination at this position, exhibits the lowest increase in H2 production among the
studied Co-cyt b562 mutants. Further, the data supports the fact that the methio-
nine coordination at this position results in a higher overall activity, as mutants
bearing this residue (WT, H102A) resulted in the highest TON values. A possible
explanation of these observations is that as the metal center becomes more electron
rich, a softer ligand—such as methionine’s thioether side chain—is capable of better
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Figure 3.5. Turnover number values obtained for CoPPIX and cobalt cyt b562 mu-
tants under irradiation with light for 8 h in 100 mM AscOH, 1 mM [Ru(bpy)3]2+,
and 200 mM KPi. The bars represent the TON of each catalyst at pH 6.0 in ab-
sence (H2: yellow) and presence of CO2 (H2: red, CO: dark blue, HCO –2 : dark
green); and in the presence of CO2 at pH 7.0 (H2: orange, CO: light blue, HCO –2 :
light green). The error bars represent the standard deviation of the sample.
44
stabilizing the reduced intermediates that are formed throughout the catalytic cy-
cle. Finally, the difference between the activities of H102A and WT can be due to
the opening of a coordination site on one side of the porphyrin, thus increasing the
chance of substrate binding to the active site.
In order to investigate if CO2 reduction was pH dependent, the catalysts
were evaluated also at pH 7.0 (Figures B.10 and B.11). The TON for CO did not
suffer any considerable changes between the mutants, consistent with the indepen-
dence of CO2 binding from proton concentration. Unsurprisingly the H2 yield for
WT, M7A, and H102A decreased by 20 %, which is to be expected when proton
concentration is decreased 10-fold. However, no significant change of H2 TON was
observed for free porphyrin or the M7H mutants, suggesting that under these con-
ditions M7H behaves similarly to CoPPIX. Finally, although formate production is
in principle dependent on proton reduction, no significant changes in turnover num-
ber were observed for this compound, which might indicate that other factors may
come into play when it comes to CO2 reduction by these catalysts in an aqueous
environment.
3.4 Conclusions
In summary, this work aimed at the design of cyt b562 mutants that incorporate
CoPPIX as cofactor and were capable of reducing protons and CO2 into H2, CO,
and HCO –2 upon light irradiation in the presence of [Ru(bpy)3]2+ and ascorbic acid
as photosensitizer and sacrificial electron donor, respectively. The proteins were
designed to investigate the effect of axial mutations on the porphyrin, including the
native ligation (WT), removal of a ligand site (M7A, H102A), or change of ligation
site (M7H). All proteins bound the porphyrin with similar affinity and exhibited
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an increase in folding stability upon binding and remained solubilized in water
throughout the experiments.
The findings indicate that CO2 reduction into CO is slightly increased when
incorporated into the protein, whereas HCO –2 production did not see any changes
between free and bound catalyst. On the other hand, proton reduction showed a
difference in activities between the mutants, indicating that both electronic and
steric effects play an important role throughout the catalytic cycle that leads to H2
production. Additionally, three of the protein scaffolds (WT, M7A, H102A) showed
a dependence of proton reduction activity at higher pH, but M7H and the free por-
phyrin did not show any noticeable change in activity at the examined pH values.
Moreover, no pH dependence of CO2 reduction activity was observed between the
catalysts, indicating that other factors may come into play in the mechanism of
CO2 reduction by these catalysts.
This work shows that it is possible to regulate the hydrogen production ac-
tivity of CoPPIX by incorporating it into cyt b562 and mutating residues involved
in the first coordination sphere of the porphyrin. Further work involving the study
of other relevant mutations at this site or the second coordination sphere could
provide insight into the mechanism(s) of these catalysts in photoinduced reduc-
tion of H+ and CO2, which in turn could have positive implications in the field of
renewable energy and green chemistry.
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CHAPTER 4
A NOVEL DITHIOL AMINO ACID FOR THE INCORPORATION OF
[FeFe]-HYDROGENASE ACTIVE SITE MIMICS INTO PROTEIN SCAFFOLDS
4.1 Introduction
The use of hydrogen as an alternative fuel has caught the interest of the scientific
community for several reasons, including its abundance, high heat of combustion
and its suitability as a green fuel, since the only product of its reaction with oxygen
is water (Reaction R-1.1). However, current processes for the production of this gas
rely on the use of precious metals or high energy processes.1,2
In nature, hydrogen metabolism is regulated by hydrogenases, enzymes that
are capable of reversibly reducing protons to hydrogen (Reaction R-1.2) with high
efficiency under mild conditions while utilizing earth-abundant metals. Of partic-
ular interest are the [FeFe]-hydrogenases, which are biased toward the production
of hydrogen gas. The active site in these hydrogenases, the H-cluster, is comprised
of a [Fe4S4] cluster tethered by a cysteine residue to the proximal iron atom of a
peculiar diiron complex. The metal atoms in the latter are coordinated by carbonyl
and biologically-unique cyanide ligands, while also being linked together by an aza-
dithiolate bridge (Figure 4.1).3–6
Recently, a wide variety of small molecule mimics of the H-cluster have been
prepared in order to elucidate the enzyme’s mechanism, with the hope of reproduc-
ing its activity without the need of the complex biological machinery needed for its
expression. These studies have shown that the nature of the ligands has an impor-
tant effect in the proton reduction mechanism, as they regulate the oxidation state
of the metals and the geometry of the catalyst, thus determining the binding mode
of the hydride and the order of protonation and electron transfer events.7–12
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Figure 4.1. (a) Modeled H-cluster of D. desulfuricans [FeFe]-hydrogenase, PDB
code: 1HFE, and (b) its corresponding line structure representation.
Unfortunately, these organometallic compounds are typically not water solu-
ble, lack the high turnover numbers of the native enzyme, are oxygen sensitive, and
often show irreversible events upon electrochemical reduction, thus making them
unsuitable for light driven catalysis where electrons must be transferred one-by-
one.7–9,13–15 The reason behind these shortcomings can be attributed to the lack of
second-sphere and long-range interactions that the natural enzymes provide. These
interactions help stabilize important intermediates during the course of the reaction
and alter their redox potential. The protein environment also provides a proton
channel that controls the movement of substrates and product to and from the
redox center.16,17 With this in mind, some research groups have ventured into ex-
ploring the utilization of a variety scaffolds to mimic the role of the protein during
catalysis and study proton reduction by this diiron complex.18
Different strategies have been utilized to incorporate mimics of the active
site of [FeFe]-hydrogenases into supramolecular structures; however, most of them
are not easily amenable to modification and offer a narrow variety of functional
groups, making it difficult to reproduce the chemically rich environment that pro-
teins offer.19–23
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Some examples can be found in the literature that make use of proteins and
peptide scaffolds, the main strategy being the use of the dithiol bridge to anchor
the diiron complex. For instance, the thiol groups of cysteine residues have been
used as anchoring points to incorporate the diiron mimic into proteins and pep-
tides.24–27
Other synthetic approaches have involved specifically targeting a particular
residue in a peptide or protein by using orthogonal groups. In the case of peptides
made through SPPS, for instance, it is possible to use an orthogonal protecting
group that can be selectively deprotected on-resin to incorporate a dithiol function-
ality, which after cleavage of the peptide can be used to anchor a diiron complex.28
For proteins, the use of the bioorthogonal maleimide-thiol reaction has been utilized
to incorporate the diiron catalyst in a similar fashion into the cavity of a protein
bearing a single cysteine residue.29
Perhaps more interestingly, our laboratory has explored the alternative of
utilizing non-natural amino acids that bear the dithiol bridge as a side chain. In
previous work, our group reported the preparation of an amino acid with a 1,3-
propanedithiol side chain that was suitable for SPPS. This amino acid was then
incorporated into a helical peptide where a diiron hexacarbonyl mimic of [FeFe]-
hydrogenase was tethered through the dithiol groups resulting in aqueous proton re-
duction catalysis in a photosensitized experiment.30 Additionally, phosphine amino
acids have also been utilized to tether the diiron complex asymmetrically, more in
line with the native cofactor.31
However, no work has been done to explore the incorporation of [FeFe]-
hydrogenase mimics that could be more suitable for photocatalysis. Studies done
on (μ-1,2-benzenedithiolato-1κ2S :2κ2S)bis(tricarbonyliron)(Fe—Fe) have shown
that upon irradiation in presence of a photosensitizer and a sacrificial electron
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donor, complexes bearing a 1,2-benzenedithiolate bridge have a higher activity
as compared to those containing an azadithiolate bridge found in the native cofac-
tor.13,32–34 DFT calculations suggest this may be due to a different mechanism in
which the bridging ligand plays a crucial role in stabilizing the reduced intermedi-
ates throughout the reaction.32
In order to evaluate this type of [FeFe]-hydrogenase mimics in aqueous con-
ditions, and with particular interest in studying how protein interactions may come
into play with the proposed mechanism, this work presents the enantioselective syn-
thesis a novel amino acid bearing 1,2-benzenedithiol as a side-chain and suitable
protecting groups for its use in Fmoc SPPS (Figure 4.2).
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Figure 4.2. Structure of target compound 4-1.
4.2 Retrosynthetic Analysis
Several synthetic routes were assayed to prepare the target molecule involving the
use of alternative ways of controlling the stereochemistry of the final reaction. The
results from these attempts were not successful and are not discussed in this chap-
ter, but a brief overview is presented in Appendix D. The most promising strategy
that was followed makes use of a nickel-based chiral auxiliary, [(N -benzyl-l-prolyl-
κN )(2-{(E)-[(carboxylato-κO-methyl)imino-κN ](phenyl)methyl}phenyl)azanido-
κN ]nickel (NiCA, Figure 4.3), which can be alkylated with a modified Mitsunobu
reaction on the corresponding benzyl alcohol.35,36 The preparation of the benzyl
alcohol could be carried from the reduction of the benzaldehyde derivative, which
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Figure 4.3. (a) Structure of NiCA and (b) rationale behind its stereospecificity.
could also be obtained from the reduction of a nitrile group. The nitrile group
activates the ring toward nucleophilic aromatic substitution, thus 3,4-dichloroben-
zonitrile (4-2) was chosen as a starting material for this synthesis (Scheme 4.1).
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Scheme 4.1. Retrosynthetic analysis for the synthesis of compound 4-1.
4.3 Results and Discussion
The synthetic route followed for the synthesis of the target compound is shown on
Scheme 4.2. Two different sulfur nucleophiles were evaluated to introduce the thiol
55
CN
Cl
Cl
4-2
(a)
CN
SR
SR
4-4
(b)
CHO
SR
SR
4-5
(c)
OH
SR
SR
4-6
(d)
N SR
SRO O
NO
NBn
Ni
4-7
(e)
H3N+© SR
SR
–©
O O
4-1
Scheme 4.2. Synthetic route for compound 4-1. (a) 4-3a or 4-3b, NaH, DMF,
0 ◦C to r. t.; (b) DIBAL, toluene, 0 ◦C; (c) NaBH4, EtOH; (d) NiCA, CMBP,
toluene, 110 ◦C; (e) MeOH, HCl, reflux.
groups on the basis of their nucleophilicity and lability as protecting groups. The
thiols thus chosen were (4-methoxyphenyl)methanethiol (4-3a), and 2-(trimethylsi-
lyl)ethanethiol (4-3b).
The nucleophilic substitution of 4-2 to obtain compounds 4-4a,b was car-
ried out by using the sodium thiolate salt of the thiols, formed in situ by their
irreversible deprotonation using NaH in DMF. Low to moderate yields were ob-
tained when 4-3a was used as compared to 4-3b, likely due to the bulkiness of the
former. Purification of 4-4a was very demanding, indicating that a number of side
reactions occurred when (4-methoxyphenyl)methyl (PMB) was used as protecting
group, which could involve the monosubstituted products, demethylation of the
methoxy group by the thiolate nucleophile, or other side products that can result
from the latter. In contrast, there was little difficulty on when the 2-(trimethylsi-
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lyl)ethyl (TMSE) group was used, in line with the lower steric hindrance and more
inert nature of this group.
Selective reduction of the nitrile with DIBAL in THF yielded the desired
aldehydes 4-5a,b in moderate to high yields with no detectable side products. Fur-
ther reduction to alcohols 4-6a,b with NaBH4 in an ethanol:water mixture also
went smoothly for all compounds in good yields.
The NiCA was prepared as reported in the literature35,37,38 and the coupling
to the obtained alcohols using CMBP in refluxing toluene was carried out without
major complications and the NiCA complexes 4-7a,b were obtained in moderate
yields. The structure of the complexes was determined by 2D NMR experiments
(PMB: Figures C.15 to C.18; TMSE: Figures C.21 to C.24).
The free amino acid with the protected thiols was recovered after acidic
hydrolysis of the NiCA complex in methanol. Surprisingly, the amino acid was
recovered in the organic phase, likely due to the high hydrophobicity of the side
chains, albeit along with the other part of the ligand as a result from the imine
hydrolysis. Due to the ionic nature of the amino acid, column chromatography
using silica gel proved complicated, as it is difficult to elute the amino acid once
it is adsorbed onto the stationary phase. An alternative is to use ion exchange
chromatography with an anion exchange resin, as at high pH values the amino
groups in both, the amino acid and the ligand, will be the deprotonated (neutral),
and the carboxylate in the amino acid will have a negative charge, thus making it
possible to elute the ligand first, and then switch to an acidic solvent to elute the
desired amino acid.
The removal of the protecting groups on 4-1 was not successful for either
protecting group. The PMB groups have proven stable on acidic cleavage using
TFA, both in DCM and neat, and to the use of mercury salts (Hg(OAc)2) in this
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same acid.39,40 Other unsuccessful attempts include the use of AgBF4 in TFA41 and
TMSCl with Ph2SO in the same solvent.42 Alternative methods that can be still
assayed include anhydrous HF or reduction of the protecting group with sodium
metal in ammonia.43
Similarly, the TMSE deprotection with tetrabutylammonium fluoride
(TBAF) in THF44 has not been successful in the deprotection of the thiol groups,
despite the fact that 4-4b did show signs of deprotection in the same conditions.
A possible explanation of this fact is that the thiolate anion that acts as leaving
group is better stabilized by the cyano group, suggesting that a stronger driving
force may be necessary for a successful reaction on the amino acid. This could be
accomplished by using a different source of fluoride ions in a less polar solvent, or
by making use of a different deprotection mechanism that simultaneously protects
the thiols from other side reactions, such as dimethyl(methylsulfanyl)sulfonium
tetrafluoroborate ((MeSSMe2)BF4).45
4.4 Conclusions
This project aimed at developing a novel artificial amino acid bearing a 1,2-ben-
zenedithiol side chain that could serve as anchoring point for embedding [FeFe]-
hydrogenase mimics into peptide and protein scaffolds. Two versions of the desired
amino acid were prepared with different protecting groups on the thiols, namely
(4-methoxyphenyl)methyl and 2-(trimethylsilyl)ethyl. Product stereochemistry was
controlled by using a nickel-based chiral auxiliary in a Mitsunobu-like reaction.
The use of this amino acid will allow future work into investigating the effect
of [FeFe]-hydrogenase organometallic mimics that may be more suitable for the
photoinduced reduction of protons, which could have important implications as
we move toward a green fuel-based society. Additionally, this amino acid can be
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used for the incorporation of other organometallic complexes, thus allowing a high
throughput exploration of the effect of the protein environment on catalysts that
are not close in structure or activity to those found in nature.46,47 Further, the
chelating nature of this particular ligand could be taken advantage of on the fields
of metal-mediated self-assembly and the design of novel protein-based materials.
4.5 Experimental Details
All reagents were purchased from Acros Organics, Alfa Aesar, Oakwood Chemicals,
Sigma Aldrich, or TCI America and used as received. All reactions were carried
out under an atmosphere of argon gas using traditional Schlenk techniques. Dry
DMF and toluene were purchased from Sigma Aldrich in SureSeal bottles and used
as received. Thin Layer Chromatography (TLC) was performed on silica plates
with a fluorescent marker (Analtech) and visualized under UV light, or by exposing
to iodine vapors, a KMnO4 stain solution, a 2,4-dinitrophenylhydrazine staining
solution, an Ellman’s reagent solution (for thiols), or a ninhydrin solution. Column
chromatography was performed using 230–400 mesh silica gel (SiliaCycle). The
compounds were characterized by NMR in a Varian 400 MHz or a Bruker 500 MHz
spectrometer.
4.5.1 Synthesis of substituted benzonitriles (4-4)
3,4-Bis{[(4-methoxyphenyl)methyl]sulfanyl}benzaldehyde (4-4a). To a sus-
pension of NaH (1.05 g, 43.6 mmol) in DMF (15 mL) was added 4-3a (6.1 mL) in
DMF (15 mL) dropwise while keeping the reaction in a water-ice bath. The suspen-
sion became clear and was stirred for 30 min at the same temperature. A solution
of 4-2 (3.0 g) in DMF (10 mL) was then added dropwise through an addition fun-
nel. The reaction mixture quickly turned to a yellow color. The water-ice bath
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was removed and the mixture was stirred overnight at room temperature. The
solvent was removed under reduced pressure and the residue diluted with water
(15 mL). The suspension was extracted with CHCl3 (3× 25 mL), the organic layers
washed with water (3× 25 mL), dried over MgSO4, and the solvent removed under
reduced pressure. The pure product was purified by column chromatography using
a hexanes:ethoxyethane (Et2O) 3:2 as a mobile phase and obtained as a white solid
(2.95 g, 35 %). m. p. 90–92 ◦C. Rf (hexanes:Et2O 3:2) 0.1. 1H NMR (400 MHz,
CDCl3): δ 7.34 (d, 1H, J = 1.4 Hz), 7.30 (dd, 1H, J = 8.2, 1.2 Hz), 7.24 (d, 2
H,J = 8.5 Hz), 7.15 (m, 3H), 6.86 (m, 4H), 4.14 (s, 2H), 4.07 (s, 2H), 3.80 (s, 3H),
3.79 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 159.10, 159.02, 145.94, 137.78, 135.93,
132.93, 130.10, 130.03, 130.03, 129.91, 129.00, 128.19, 127.77, 127.04, 126.37, 125.27,
113.11, 113.97, 108.54, 55.23, 55.22, 37.71, 36.66.
3,4-Bis{[(2(trimethylsilyl)ethyl]sulfanyl}benzonitrile (4-4b). The
procedure was similar to the one used for 4-4a, using 1.79 mL (11.2 mmol) of 4-3b
as thiolate, 286 mg (11.9 mmol) of NaH, and 640 mg (3.72 mmol) of 4-2. The com-
pound was purified through column chromatography using hexanes:Et2O 92.5:7.5
as mobile phase, and obtained as a clear oil (937 mg, 68 %). Rf (hexanes:Et2O
92.5:7.5) 0.43. 1H NMR (400 MHz, CDCl3): δ 7.42 (d, 1H, J = 1.7 Hz), 7.38 (dd,
1H, J = 8.2, 1.7 Hz), 7.17 (d, 1H, J = 8.2 Hz), 2.96 (m, 4H), 0.96 (m, 4H), 0.07
(s, 9H), 0.06 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 145.65, 137.19, 131.04, 129.17,
125.61, 118.97, 108.30, 29.54, 28.53, 16.46, 16.00, −1.66.
4.5.2 Synthesis of substituted benzaldehydes (4-5)
3,4-Bis{[(4-methoxyphenyl)methyl]sulfanyl}benzaldehyde (4-5a). To a
stirred solution of 4-4a (2.95 g, 7.2 mmol) in dry toluene (70 mL) at 0 ◦C, DIBAL
in toluene (25 % w/v in toluene, 9.9 mL, 14.5 mmol) was added dropwise through
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an addition funnel. After the addition was completed, the reaction was stirred
for 3 h at 0 ◦C, and then quenched by the dropwise addition of 3 mL of acetone,
followed by the dropwise addition of half-saturated aqueous solution of Rochelle’s
salt (sodium potassium tartrate, 25 mL). The reaction was let warm up to room
temperature and stirred overnight until the layers were separated. The aqueous
layer was extracted with ethyl acetate (EtOAc) (3× 50 mL), the organic fractions
combined, and washed with brine (50 mL), dried over MgSO4, and the solvent was
removed in vacuo. The product was purified through column chromatography using
hexanes:EtOAc 1:1 as mobile phase and obtained as a yellow oil (2.81 g, 95 %). Rf
(hexanes:EtOAc 1:1) 0.56. 1H NMR (400 MHz, CDCl3): δ 9.72 (s, 1H), 7.58 (d, 1H,
J = 1.6 Hz), 7.49 (dd, 1H, J = 8.1, 1.6 Hz), 7.20 (d, 3H, J = 8.5 Hz), 7.09 (d, 2H,
J = 8.6 Hz), 6.76 (d, 2H, J = 8.6 Hz), 6.70 (d, 2H, J = 8.6 Hz), 4.06 (s, 2H), 4.01
(s, 2H), 3.69 (s, 3H), 3.67 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 191.03, 159.25,
159.10, 148.15, 135.39, 133.54, 131.41, 130.34, 130.25, 128.46, 128.30, 127.43, 126.16,
114.28, 114.09, 55.44, 55.41, 38.05, 36.89.
3,4-Bis{[(2-(trimethylsilyl)ethyl]sulfanyl}benzaldehyde (4-5b). This
compound was synthesized using the same procedure as outlined for 4-5a using
937 mg (2.55 mmol) of 4-4b and 3.48 mL (5.10 mmol) of DIBAL (25 % w/v in
toluene) in 25 mL of toluene. The compound was obtained after purification via
column chromatography (hexanes:Et2O 9:1), yielding a yellow oil (819 mg, 87 %).
Rf (hexanes:Et2O) 0.46. 1H NMR (400 MHz, CDCl3): δ 9.90 (s, 1H), 7.72 (d, 1H,
J = 1.7 Hz), 7.61 (dd, 1H, J = 8.1, 1.7 Hz), 7.25 (d, 1H, J = 8.1 Hz), 3.03 (m, 4H),
0.98 (m, 4H), 0.08 (s, 9H), 0.05 (s, 9H). 13C NMR (100 MHz, CDCl3): δ 191.18,
147.92, 136.35, 133.24, 129.15, 127.83, 125.20, 29.49, 28.50, 16.70, 16.05, −1.62.
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4.5.3 Synthesis of substituted benzyl alcohols (4-6)
(3,4-Bis{[(4-methoxyphenyl)methyl]sulfanyl}phenyl)methanol (4-6a). To
a solution of 4-5a (2.82 g, 6.9 mmol) in THF:EtOH 2:3 (25 mL) cooled at 0 ◦C was
added NaBH4 (628 mg, 2.4 mmol) in portions. The reaction was stirred for 3 h at
room temperature and then poured onto HCl 2 N (25 mL) containing ice (30 g).
The suspension was then extracted with CHCl3 (3× 50 mL), the organic layers
dried with MgSO4, and the solvent removed with a rotary evaporator. The com-
pound is purified through column chromatography using hexanes:EtOAc 1:2 to
obtain an off-white solid (2.29 g, 81 %). Rf (hexanes:EtOAc 1:2) 0.50. 1H NMR
(400 MHz, (CD3)2CO): δ 7.37 (d, 1H, J = 1.3 Hz), 7.72 (m, 5H), 7.11 (dd, 1H,
J = 8.0, 1.3 Hz), 6.84 (m, 4H), 4.57 (d, 2H, J = 3.8 Hz), 4.22 (br, 1H), 4.13 (s, 2
H), 4.10 (s, 2H), 3.76 (s, 3H), 3.75 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 159.95,
159.89, 142.29, 138.52, 135.44, 131.14, 131.05, 130.91, 130.19, 129.93, 128.10, 125.41,
114.71, 114.66, 64.17, 55.58, 55.57, 38.05, 37.79.
(3,4-Bis{[2-(trimethylsilyl)ethyl]sulfanyl}phenyl)methanol (4-6b).
The same procedure as for the preparation of 4-6a was followed using 762 mg
(2.06 mmol) of 4-5b and 156 mg (4.12 mmol) of NaBH4 in 8.2 mL of ethanol. Af-
ter purification by column chromatography (hexanes:EtOAc 4:1) the compound was
obtained as a yellow oil (732 mg, 96 %). Rf (hexanes:EtOAc 4:1) 0.44. 1H NMR
(400 MHz, CDCl3): δ 7.25 (m, 2H), 7.12 (dd, 1H, J = 8.0, 1.9 Hz), 4.66 (s, 2H),
2.95 (m, 4H), 1.67 (br, 1H), 0.95 (m, 4H), 0.05 (s, 9H), 0.04 (s, 9H). 13C NMR
(100 MHz, CDCl3): δ 138.98, 138.28, 136.56, 129.22, 127.09, 124.71, 65.09, 29.45,
29.14, 16.70, 16.60, −1.58, −1.61.
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4.5.4 Synthesis of alkylated NiCA complexes (4-7)
[(N -Benzyl-l-prolyl-κN ){2-[{(E)-[(2S)-(3,4-bis{[(4-methoxyphenyl)-
methyl]sulfanyl}phenyl)-1-carboxylato-κO-ethyl]imino-κN}(phenyl)-
methyl]phenyl}azanido-κN ]nickel (4-7a). A solution of 4-6a (596 mg,
1.45 mmol), NiCA (1.44 g, 2.89 mmol), and CMBP (380 µL), 1.45 mmol) in dry
toluene (725µL) was stirred and refluxed at 120 ◦C overnight. After the reaction
was complete, the solvent was evaporated under reduced pressure and the crude
mixture was purified through column chromatography using DCM 9:1 as mobile
phase. The compound was obtained as a crystalline orange-red powder (714 mg,
55 %). When 2 eq of 4-5a and CMBP where used in the presence of 1 eq of NiCA
the yield was 96 % based on NiCA. Rf (DCM:acetone 9:1) 0.3. 1H NMR (500 MHz,
CDCl3): δ 8.34 (dd, 1H, J = 8.8, 1.2 Hz), 8.01 (d, 2H, J = 6.8 Hz), 7.50 (m, 2H),
7.39 (m, 1H), 7.28 (m, 6H), 7.16 (m, 2H), 7.00 (d, 2H, J = 8.6 Hz), 6.90 (m, 2H),
6.81 (m, 2H), 6.68 (m, 4H), 6.43 (dd, 1H, J = 7.6, 1.7 Hz), 4.23 (m, 2H), 4.10 (d, 2
H, J = 3.2 Hz), 3.84 (m, 2H), 3.78 (s, 3H), 3.76 (s, 3H), 3.43 (d, 1H, J = 12.6 Hz),
3.31 (dd, 1H, J = 9.8, 7.2 Hz), 3.05 (m, 1H), 2.92 (dd, 1H, J = 13.8, 4.2 Hz), 2.61
(dd, 1H, J = 13.8, 5.6 Hz); 2.33 (m, 3H), 1.93 (m, 1H), 1.61 (m, 1H) . 13C NMR
(125 MHz, CDCl3): δ 180.54, 178.40, 171.13, 158.85, 158.66, 143.04, 139.65, 134.68,
134.11, 133.63, 133.41, 132.52, 131.50, 130.62, 130.13, 130.10, 129.91, 129.79, 129.06,
128.85, 128.77, 128.10, 127.91, 127.88, 127.03, 125.92, 123.54, 120.51, 113.94, 113.86,
113.83, 71.13, 70.30, 63.40, 57.53, 55.28, 55.25, 38.84, 37.86, 36.25, 30.82, 23.13.
[(N -Benzyl-l-prolyl-κN ){2-[{(E)-[(2S)-(3,4-bis{[2-(trimethylsilyl)-
ethyl]sulfanyl}phenyl)-1-carboxylato-κO-ethyl]imino-κN}(phenyl)methyl]-
phenyl}azanido-κN ]nickel (4-7b). A mixture of 4-6b (732 mg, 1.96 mmol),
NiCA (1.97 g), 3.93 mmol), and CMBP (515µL, 1.96µL) in dry toluene (4 mL) was
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stirred and refluxed at 120 ◦C overnight. The solvent was then removed under re-
duced pressure and the crude mixture was purified via column chromatography us-
ing a gradient from DCM:acetone 99:1 to DCM:acetone 95:5 to obtain a red-orange
oil (826 mg, 49 %). Rf (DCM:acetone 99:1) 0.26. 1H NMR (500 MHz, CDCl3): δ
8.23 (d, 1H, J = 8.7 Hz), 8.03 (d, 2H, J = 7.0 Hz), 7.51 (m, 2H), 7.40 (m, 1H),
7.27 (m, 4H), 7.14 (m, 2H) 6.96 (m, 2H), 6.66 (m, 3H), 4.28 (m, 2H), 3.43 (d, 1H,
J = 12.7 Hz), 3.33 (dd, 1H, J = 10.0, 7.1 Hz), 3.15 (m, 2H), 2.95 (m, 2H), 2.79 (m,
3H), 2.53 (m, 1), 2.38 (m, 2H), 2.00 (m, 1H), 1.77 (m, 1H), 0.93 (m, 4H), 0.03 (s,
9H), −0.01 (s, 9H). 13C NMR (125 MHz, CDCl3): δ 180.53, 178.53, 171.16, 143.06,
138.85, 135.88, 134.19, 133.65, 133.43, 132.50, 131.61, 129.79, 129.09, 129.05, 128.88,
128.88, 128.51, 127.97, 127.72, 127.30, 126.16, 123.56, 120.65, 71.53, 70.48, 63.44,
57.65, 39.78, 30.99, 29.20, 28.58, 23.37, 16.59, 16.18, −1.62, −1.64.
4.5.5 General procedure for the synthesis of 4-1
(S)-2-Amino-3-(3,4-bis{[(4-methoxyphenyl)methyl]sulfanyl}phenyl)-
propanoic acid (4-1a). Compound 4-7a (52 mg, 58µmol) was refluxed in
methanol (1.2 mL) in presence of HCl (60 µL, 120 µmol) for 2 h to obtain a blue-
green solution. The solvent was then removed under reduced pressure. The crude
product was redissolved in water (5 mL), and extracted with DCM (3× 5 mL). The
organic extracts were dried over MgSO4 and the solvent evaporated. The product
was not isolated.
(S)-2-Amino-3-(3,4-bis{[2-(trimethylsilyl)ethyl]sulfanyl}phenyl)-
propanoic acid (4-1b). A mixture of 4-7b (150 mg, 0.176 mmol) and HCl 2 M
(1.76 mL, 3.52 mmol) in methanol (3.5 mL) was refluxed for 2 h and the solvent then
removed under reduced pressure. The residue was treated with water (10 mL) and
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extracted with DCM (3× 10 mL). The organic fractions were combined and dried
over MgSO4, and the solvent removed in vacuo. The product was not isolated.
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CHAPTER 5
CONCLUDING REMARKS AND FUTURE OUTLOOK
Over millions of years of evolution, nature has selected a rich variety of metalloen-
zymes that make use of earth-abundant metals embedded in a protein architec-
ture in order to catalyze a wide array of redox reactions. As such, studying the
effect that the protein plays in regulating the activity of these metal-based catalytic
centers has become a growing field of study. In particular, the design of artificial
metalloenzymes with tailored activities has become the objective of many research
groups, as current methodologies to carry out the production of valuable goods—
such as renewable fuels—typically involve the use of expensive and energy intensive
methodologies.
This thesis explored the design of metalloproteins with aims at building a
multicomponent system that could integrate the several parts of a light-driven re-
dox catalytic reaction, such as the light absorbing component, an electron transport
chain, and the catalytic center. Further, it also discussed the use of two strategies
to incorporate catalytic centers into protein and peptide environments in order to
enhance their catalytic properties in the reduction of protons into hydrogen gas and
carbon dioxide into other reduced carbon species.
Since each part of the redox process has its own particular requirements, the
best approach would be to develop a strategy that can be used to bring each of the
elements together. The first part of this dissertation makes use of 2,2′-bipyridine as
a ligand to template the metal-driven trimerization of peptides. By covalently at-
taching this ligand to DSD, a robust protein scaffold that forms dimers in solution,
it was shown that addition of divalent metals results in the trimerization of these
dimers, effectively forming a hexameric supramolecular architecture. The results
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also indicate that the degree of oligomerization strongly depends on the sequence
of the peptide and the nature of the metal ion, as thermodynamics and kinetics of
the formation of the tris(bpy) complexes has an effect in the folding of the designed
peptides.
In particular, this strategy can be not only utilized for the assembly of the
desired components into a supramolecular machinery, but the use of the tris(bpy)
functionality opens up the door for the formation of photoactive complexes, which
may be utilized as the light absorbing centers of the system. Future experiments
with this strategy would then aim at incorporating the electron transfer and cat-
alytic modules into a single structure, as well as introducing a photoactive species
into the architecture, whether it be by integration of a third subunit, or by making
use of photoactive tris(bpy) moieties.
With a system capable of combining the necessary components into a sin-
gle entity, this dissertation then explores the use and development of strategies
that make use of proteins or peptides as scaffolds that incorporate earth-abundant
organometallic complexes in order to enhance their properties through the effect of
the surrounding environment.
The first of these strategies made use of a host-guest approach by incorpo-
rating the cobalt version of heme, cobalt protoporphyrin IX, into cytochrome b562,
a natural heme-binding protein. In this particular enzyme, the protein not only
serves as a support for the metal complex, but it also provides two coordinating
ligands that can alter the properties of the bare compound. Taking this into con-
sideration, the underlying hypothesis of this work was that modification of these
particular ligands would have an effect in the catalytic properties of this complex.
Further, in order to evaluate their potential use as catalysts for the target reactions
in an environmentally friendly fashion, the activity of these constructs was assayed
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in the presence of a photosensitizer/sacrificial electron donor; consequently, light
was the primary energy source to drive these catalytic reactions.
There are three key aspects that are worth highlighting. First, incorporation
of the porphyrin into any of the studied protein structures resulted in active cata-
lysts that remained water soluble throughout the time span of the experiments, as
opposed to the porphyrin which quickly precipitated in water. Additionally, all of
the designed metalloenzymes were active toward proton and CO2 reduction, pro-
ducing molecular hydrogen from the former, and carbon monoxide and formic acid
from the latter, and total turnover number was enhanced for the production of hy-
drogen and carbon monoxide upon reconstitution of the protein with the cobalt
porphyrin. Finally, the total activity for hydrogen production varied between the
analyzed mutants, while that of CO and HCO2H remained the same. This impor-
tant finding supports the hypothesis that modification of the axial ligands would
result in modification of the catalytic activity. Interestingly, these results also sug-
gest that although the observed effect of the studied mutations may operate on
certain reactions, it may not be as evident in others.
This last statement presents an opportunity for future work with this sys-
tem. Exploring the functional groups that can be incorporated into the protein
sequence—and now not only limited to natural amino acids but also a library of ar-
tificial ones—future endeavors may seek to characterize the effect of other residues
that may act as ligands in order to observe an effect on the catalytic reduction of
CO2 or to further improve on the activity of hydrogen generation. Moving forward,
modification of residues surrounding the active site might offer not only better cata-
lysts, but also insight into the mechanism of the reactions at play, thus resulting in
a better foundation for the rational design of this and other metalloenzymes.
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While this approach has proven useful for incorporating a catalyst that is
not found in nature to a guest protein, it is limited in the sense that this and re-
lated proteins are designed to bind the same type of cofactors due to the nature of
the binding pocket. In order to expand the range of organometallic complexes that
could be incorporated into the protein environment a different strategy has been
developed. This dissertation has also presented a suitable alternative to incorporate
another class of catalysts by describing the preparation of an unnatural amino acid
bearing a 1,2-benzenedithiol side chain. Two versions of the amino acids have been
prepared through an enantioselective route that yielded the amino acid in the same
configuration as natural amino acids. The two amino acids differ in the protecting
groups for the thiol groups, one with PMB and TMSE, respectively.
This novel amino acid resembles the dithiol bridge present in the unique
active site of [FeFe]-hydrogenases, thus it is suitable for the incorporation of mimics
of this catalytic center. Moreover, complexes bearing this non-innocent ligand have
been shown to have enhanced catalytic activity when used during the light driven
reduction of protons, likely due to the stabilization of the one-electron reduced
species that are inherently formed throughout the process.
Non-natural amino acids are a powerful tool when it comes to conferring
new functionality to proteins. This particular functional group is interesting in the
metalloenzyme field as it offers a new chelating ligand capable of binding metals,
particularly in lower redox states due to the soft nature of the thiolate groups, and
stabilizing radical intermediates. Moving forward, two general pathways for the
use of this amino acid can be outlined. First, the incorporation of the amino acid
into small peptides by automated solid phase synthesis should be straightforward
from the Fmoc protected compound. In this way organometallic complexes can be
reconstituted to form water soluble versions thereof. Perhaps of interest could be to
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take advantage of the orthogonality of the protecting groups that have been used,
as this would allow the introduction of different metal functionalities on different
positions of the same structure.
The second pathway would be the introduction of the amino acid into pro-
tein scaffolds by making use of amber codon suppression technology, which allows
the incorporation of non-natural amino acids into protein sequences by using a
tRNA/tRNA aminoacyl synthase pair that is orthogonal to the cell expression sys-
tem. The success of this approach would greatly broaden the scope not only of
protein environments that can be used to analyze their effects on organometallic
mimics, but also for the high-throughput screening for finding the best scaffolds for
a particular complex, or even directed evolution methods to select for them.
Ultimately, this thesis has contributed to the field of metalloprotein design
by offering strategies to incorporate catalysts into proteins, exploring the effect of
protein environment on catalysts, and providing a methodology for the assembly
of components of a multi-domain protein based redox system. Overall, the results
of this thesis are compatible with current research efforts as they expand on the
interaction between proteins and metals upon catalysis, while setting the starting
point for future projects in the area. The mechanistic insight gathered through
these projects will help with the development of new and better protein-based cata-
lysts and the chemical principles behind them could also further be applied to other
materials, thus playing an important role in the development of new technologies
that can satisfy our society’s growing energetic demand in a sustainable way.
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Figure A.1. MALDI-TOF-MS spectra of (a) HB1 and (b) HB2.
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Figure A.2. UV-Vis traces for the titration of HB1 (black trace) with CoCl2 (top)
or NiCl2 (blue traces).
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Figure A.3. Binding curves of HB1 titrated with CoCl2 (left) and NiCl2 (right) as
monitored by UV-Vis. The calculated binding stoichiometry was (a) 3.4 peptides
per metal ion, (b) 3.5 peptides per metal ion.
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Figure A.4. CD spectra of HB1 (red), CoHB1 (blue), and NiHB1 (green).
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Figure A.5. Thermal denaturation curves of HB2 (red), CoHB2 (blue), and
NiHB2 (green). Molar ellipticity was followed at 222 nm.
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Figure A.6. UV-Vis (left) and CD (right) data for bpy-4-CO2H ((2,2’-bipyridine)-
6-carboxylic acid, red trace), [Co(bpy-4-CO2H)3]2+ (blue traces), and [Ni(bpy-4-
CO2H)3]2+ (green traces). Spectra obtained in 100 mM Tris·HCl buffer at pH 8.5.
The [Co(bpy-4-CO2H)3]2+ sample contains total concentrations of [CoCl2] =
41.3 µM and [bpy-4-CO2H] = 187 µM; the [Ni(bpy-4-CO2H)3]2+ sample was prepared
with a total concentration of [Ni(OAc)2] = 30.6 µM and [bpy-4-CO2H] = 140 µM.
The [bpy-4-CO2H] in the red trace was 187 µM.
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Figure A.7. Titration of 10 mM Tris buffer pH 8.0 (left) and 76.5µM Hex-Phe
(right) in the same buffer with CoCl2.
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Figure A.8. Titration of 10 mM Tris buffer pH 8.0 (left) and 76.5µM Hex-Phe
(right) in the same buffer with NiCl2.
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Figure A.9. Sedimentation AUC of Hex-Phe alone (red) and in the presence of
Co(II) (blue) or Ni(II) (green). The three species sediment with the same coeffi-
cient indicating no changes to the oligomerization state.
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Figure B.1. UV-Vis traces (top) and fitted binding isotherm (bottom) for the
titration of CoPPIX (0.89µM, black trace) with cyt b562 WT in 1 M KPi pH 6.0.
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Figure B.2. UV-Vis traces (top) and fitted binding isotherm (bottom) for the
titration of CoPPIX (3.86µM, black trace) with cyt b562 M7A in 1 M KPi pH 6.0.
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Figure B.3. UV-Vis traces (top) and fitted binding isotherm (bottom) for the
titration of CoPPIX (2.40µM, black trace) with cyt b562 M7H in 1 M KPi pH 6.0.
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Figure B.4. UV-Vis traces (top) and fitted binding isotherm (bottom) for the
titration of CoPPIX (1.05µM, black trace) with cyt b562 H102A in 1 M KPi pH 6.0.
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Figure B.5. CD spectra (top) and thermal denaturation curves (bottom) of apo
(black) and holo (red) cobalt cyt b562 M7H.
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Figure B.6. CD spectra (top) and thermal denaturation curves (bottom) of apo
(black) and holo (red) cobalt cyt b562 H102A.
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Figure B.7. Calibration curve for H2. The data was fitted to the linear equation
y = 0.679− 2.27, with an adjusted R2 = 0.9970.
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Figure B.8. Calibration curve for CO. The data was fitted to the linear equation
y = 17.62x− 107.97, with an adjusted R2 = 0.9958.
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Figure B.9. Produced H2 over time from the photoinduced reduction of protons
by CoPPIX and cobalt cyt b562 mutants at pH 6.0 under Ar. The experiments
were carried out in 100 mM AscOH, 1 mM [Ru(bpy)3]2+, 200 mM KPi, and 20µM
catalyst. The error bars represent the standard deviation of the sample.
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Figure B.10. Produced H2 over time from the photoinduced reduction of protons
by CoPPIX and cobalt cyt b562 mutants at pH 7.0 under 1 atm CO2. The experi-
ments were carried out in 100 mM AscOH, 1 mM [Ru(bpy)3]2+, 200 mM KPi, and
20 µM catalyst (when appropriate). The error bars represent the standard deviation
of the sample.
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Figure B.11. Produced CO over time from the photoinduced reduction of protons
by CoPPIX and cobalt cyt b562 mutants at pH 7.0 under 1 atm CO2. The experi-
ments were carried out in 100 mM AscOH, 1 mM [Ru(bpy)3]2+, 200 mM KPi, and
20 µM catalyst. The error bars represent the standard deviation of the sample.
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Figure C.1. 1H NMR spectrum of compound 4-4a. The red star indicates traces
of toluene as impurity.
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Figure C.2. 13C NMR spectrum of compound 4-4a. The red stars indicate traces
of toluene as impurity.
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Figure C.3. 1H NMR spectrum of compound 4-4b.
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Figure C.4. 13C NMR spectrum of compound 4-4b.
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Figure C.5. 1H NMR spectrum of compound 4-5a.
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Figure C.6. 13C NMR spectrum of compound 4-5a.
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Figure C.7. 1H NMR spectrum of compound 4-5b.
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Figure C.8. 13C NMR spectrum of compound 4-5b.
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Figure C.9. 1H NMR spectrum of compound 4-6a.
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Figure C.10. 13C NMR spectrum of compound 4-6a.
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Figure C.11. 1H NMR spectrum of compound 4-6b.
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Figure C.12. 13C NMR spectrum of compound 4-6b.
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Figure C.13. 1H NMR spectrum of compound 4-7a.
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Figure C.14. 13C NMR spectrum of compound 4-7a.
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Figure C.15. COSY spectrum of compound 4-7a.
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Figure C.16. 1H-13C HSQC spectrum of compound 4-7a.
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Figure C.17. 1H-13C H2BC spectrum of compound 4-7a.
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Figure C.18. 1H-13C HMBC spectrum of compound 4-7a.
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Figure C.19. 1H NMR spectrum of compound 4-7b.
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Figure C.20. 13C NMR spectrum of compound 4-7b.
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Figure C.21. COSY spectrum of compound 4-7b.
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Figure C.22. 1H-13C HSQC spectrum of compound 4-7b.
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Figure C.23. 1H-13C H2BC spectrum of compound 4-7b.
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Figure C.24. 1H-13C HMBC spectrum of compound 4-7b.
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APPENDIX D
ATTEMPTED ALTERNATIVE SYNTHETIC ROUTES FOR CHAPTER 4
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Chapter 4 has discussed the synthetic approach followed for the synthesis of an
unnatural amino acid that contains a 1,2-benzenedithiol side chain (4-1). This Ap-
pendix presents an overview of the synthetic strategies that were also attempted
with aims at preparing 4-1, but that were unsuccessful or not further pursued. The
work presented herein utilized different methodologies to control the stereochem-
istry of the amino acid moiety, introduce the sulfur groups into the aromatic ring,
and/or make use of different protecting groups on the thiol groups in order to be
able to facilitate their deprotection.
First, some of the planned reactions involved the use of the same synthetic
scheme presented in Scheme 4.2 but with different thiols (Table D.1), namely
methanethiol (4-3c), 2-methylpropane-2-thiol (4-3d), phenylmethanethiol 4-3e,
(2,4-dimethoxyphenyl)methanethiol (4-3f),1 (2,4,6-trimethoxybenzyl)methanethiol
(4-3g),1 and triphenylmethanethiol (4-3h). In the case of 4-3c the reaction with
4-2 seemed to go with high yields as expected from the small nucleophile, which
is consistent with the observations discussed in Section 4.3. However, upon reduc-
tion with DIBAL to the corresponding aldehyde, the 1H NMR spectrum showed
two singlets in the low field region corresponding to the CHO proton, indicating
that an inseparable mixture of compounds had been obtained; thus, this synthesis
was abandoned. When 4-3d,h were used no reaction was observed, likely due to
steric crowding of the nucleophile. Similarly, reactions with 4-3i,j resulted in com-
plex mixtures that ended up in very low yields after difficult purifications. Finally,
4-3e behaved similarly to PMB, which was discussed in the main text, albeit with
slightly lower yields. As with the case of PMB, attempts for the deprotection of the
group in the same conditions as were not successful.
One of the attempted strategies aimed at preparing the benzyl alcohol syn-
thon 4-6, albeit introducing the sulfur groups through a Newman-Kwart rearrange-
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Table D.1. Structure of the screened thiols for the preparation of compound 4-4.
Thiol (4-3) Structure
a SH
OMe
b Si SH
c CH3SH
d SH
e SH
f SH
OMeOMe
g
OMe
SH
OMeOMe
h
SH
ment (Scheme D.1).2,3 Briefly, 3,4-dihydroxybenzoic acid is transformed into its
methyl ester and the phenol groups modified with N,N -dimethylthiocarbonyl chlo-
ride to yield the corresponding bis(O-thiocarbamate). These functional groups
undergo a rearrangement reaction at high temperature (240 ◦C) and, in this partic-
ular molecule, form a cyclic S,S ′-dithiocarbonate dithioester. Basic hydrolysis of
the latter yields 3,4-disulfanylbenzoic acid. This Newman-Kwart rearrangement,
although previously reported in the literature, failed to give yields above 20 % and
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CO2Me
OH
OH
(a)
CO2Me
O
S
NMe2
O
S
NMe2 (b)
CO2Me
S
O
S
(c)
CO2H
SH
SH
BocHN
OH
HO
CO2Me
(a)
BocHN
O
S
NMe2
O
SNMe2
CO2Me
(b)
BocHN
S
O
S
CO2Me
Scheme D.1. Alternative synthetic route for 4-1 involving a Newman-Kwart re-
arrangement from 3,4-dihydroxybenzoic acid (top sequence) or l-DOPA (bottom
sequence). (a) Me2NC(S)Cl, DABCO, DMF; (b) Ph2O, 240 ◦C; (c) NaOH.
resulted in a very difficult mixture to purify, thus the approach was abandoned as it
was still necessary to protect the thiols with a group stable to reducing conditions
that would convert the carboxylic acid into the desired benzyl alcohol. Nonetheless,
this approach was also attempted with 3,4-dihydroxyphenylalanine, a naturally oc-
curring amino acid known as l-DOPA. It is likely that the absence of an electron
withdrawing group on the ring was the reason the rearrangement did not occur in
this case.
Other alternatives for the preparation of synthon 4-6 relied in the use
of thiosulfate sodium salts, which can be introduced into an aromatic ring via
a copper(I) catalyzed reaction between an aryl halide and sodium thiosulfate
(Scheme D.2).4 The strategy was first tried on 4-2 but no reaction was observed.
To rule out the effect of the halide group, 3,4-diiodobenzonitrile was prepared
from 3-amino-4-iodobenzonitrile via diazotization and substitution by KI. The aryl
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CN
NH2
I
(b)
CN
I
I
(a)
CN
S2
–©
O3
S2
–©
O3
(c)
CN
SR
SR
CN
Cl
Cl
(a)
Scheme D.2. Alternative synthetic route for 4-1 involving the preparation of
thiosulfate salts. (a) CuI, DMEDA, Na2S2O3, DMSO; (b) i) NaNO2, TsOH, ii) KI;
(c) RMgCl.
diiodide did not react under the reaction conditions, suggesting that steric crowding
was the cause of the lack of reactivity.
The last strategy that aimed at using NiCA to control the stereochemistry
is based on the use of the benzyl bromide instead of the benzyl alcohol. This was
tried using the acetamidomethyl (Acm) protecting group, introduced by treating
4-methylbenzene-1,2-dithiol with N -hydroxymethylacetamide in acidic conditions.
The bis(Acm) derivative was then brominated at the benzylic carbon with N -bro-
mosuccinimide (NBS) in moderately low yields. Upon treatment of NiCA with this
benzyl bromide in basic conditions, the desired product was not obtained, presum-
ably due to side reactions involving the hydrolysis of the acetamide functionality.
129
CH3
SH
SH
(a)
CH3
SAcm
SAcm
(b)
CH2Br
SAcm
SAcm
(c)
N SAcm
SAcmO O
NO
NBn
Ni
Scheme D.3. Alternative synthetic route for 4-1 using Acm as a thiol protecting
groups for the coupling of NiCA to the corresponding benzyl bromide. (a) AcNH-
CH2OH, HCl, DMF; (b) i) NBS, AIBN, DCE; (c) NiCA, NaOH, MeCN.
Two of the proposed synthetic routes diverge from compound 4-5 in the
scheme shown presented in Chapter 4. The first of these is based on the formation
of the corresponding hydantoin and subsequent hydrolysis to form the aryl pyru-
vate, which can be enzymatically converted to the corresponding amino acid by
aminotransferases (Scheme D.4).5,6 Unfortunately, the hydantoin coupling did not
work under the evaluated acetate/acetic acid system. The other alternative is based
on formation of the cinnamic acid, which was accomplished through a Knoevenagel
CHO
SPMB
SPMB
(a)
NH
O
NH
O
SPMB
SPMB
(b)
O
C
–©
O2
SPMB
SPMB
(c)
+©
NH3
C
–©
O2
SPMB
SPMB
Scheme D.4. Alternative synthetic route for 4-1 through formation of the corre-
sponding hydantoin. (a) NaOAc, HCl, DMF; (b) NaOH; (c) aminotransferase.
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CHO
SPMB
SPMB
(a)
CO2H
SPMB
SPMB
(c)
OH
OH
CO2Me
SPMB
SPMB
(d)
OH
CO2Me
SPMB
SPMB
(b)
+©
NH3
C
–©
O2
SPMB
SPMB (e)
Scheme D.5. Alternative synthetic route for 4-1 via cinnamic acid formation. (a)
malonic acid, β-alanine, pyridine; (b) phenylalanine/tyrosine ammonia lyase; (c)
AD-mix-α; (d) Et3SiH, TFA, DCM; (e) i) DPPA, DIAD, PPh3, ii) H2, Pd/C, iii)
LiOH.
reaction on 4-5a with good yields.7 The cinnamic acid can be transformed to the l-
amino acid in two ways: 1) by an enzymatic reaction using phenylalanine/tyrosine
ammonia lyase;8,9 or 2) through a proposed synthetic sequence that involves the
asymmetric Sharpless dihydroxylation, regioselective reduction of the benzylic al-
cohol, Mitsunobu substitution of the α-alcohol with azide, and reduction of the
latter to yield the amine group (Scheme D.5).10 These proposed synthetic path-
ways were not attempted due to the inability to remove the protecting groups, but
would still be interesting to pursue once the conditions for the thiol deprotection
are optimized.
Another option to using the NiCA involved the catalyzed sp3 directed aryla-
tion of l-alanine.11 This strategy requires an iodide group on the aromatic ring at
the coupling position. Two different pathways were devised for the preparation of
the aryl iodide bearing the protected dithiol groups. The first one involved the elec-
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PhthHN CONHArF
+ Ar I
PhthHN
Ar
CONHArF
Scheme D.6. General reaction for the directed sp3 arylation of l-alanine. The con-
ditions for the reaction are: Pd(TFA)2, 2-picoline, TFA, Ag2CO3, DCE. Phth = ph-
thaloyl, ArF = 2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenyl. Edited from reference
11.
trophilic aromatic substitution on 2-aminobenzenesulfonic acid with ICl,12 which
yielded the desired compound in moderately good yields (Scheme D.7). The potas-
sium 4-iodobenzene-1,2-disulfonate salt was later obtained by a Leuckart thiophenol
reaction followed by exhaustive oxidation with KMnO4. Attempts to obtain the
disulfonyl chloride for further reduction to the thiols with PCl5 were unsuccessful.
Another pathway that avoids simultaneous formation of the disulfonyl chlo-
ride began with 4-iodobenzenesulfonyl chloride, which was reduced to the thiol
with PPh3 in good yields,13 and then protected as a methyl thioether in moderately
good yields (Scheme D.7). The synthetic sequence aimed at introducing the sul-
SO3H
NH2 (a)
I
SO3H
NH2
(b)
I
S
–©
O3
S
–©
O3
(c)
I
SO2Cl
SO2Cl
(d)
I
SMe
SMe
I
SO2Cl
(d)
I
SMe
(e)
I
SO2Cl
SMe
(d)
Scheme D.7. Aryl iodide preparation for directed l-alanine arylation. (a) ICl,
HCl, H2O; (b) i) KNO2, HCl, ii) EtOC(S)SK, H2O, iii) KMnO4, H2O; (c) PCl5,
150 ◦C; (d) i) PPh3, PhMe, ii) CH3I, K2CO3; (e) ClSO3H, CHCl3, reflux.
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fonyl chloride group with chlorosulfonic acid, followed by another reduction with
PPh3 to yield the free thiol which could be protected with an appropriate protect-
ing group. This sequence would allow the introduction of orthogonal groups to each
of the thiols, which could be attractive for some applications. The chlorosulfona-
tion reaction resulted in a variety of products that were difficult to handle, and the
product was not able to be isolated.
Finally, the last proposed synthetic route involved the formation of the ben-
zene ring via a catalyzed [2+2+2] cycloaddition reaction involving an appropriate
bis(thioalkyne) and l-propargylglycine (l-Prg) (Scheme D.8).14,15 The procedure
to prepare the bis(thioalkyne) involved the use of trimethylsilylacetylene, which
was deprotonated with n-BuLi and treated with elemental sulfur. Attempts to trap
the thioalkyne with di(1H -imidazol-1-yl)methanone (Im2CO) and di(1H -imidazol-
1-yl)methanethione (Im2CS) were unsuccessful; but attempts to trap with oxalyl
chloride, for example, could be interesting to investigate moving forward.
TMS
(a)
X
S TMS
S TMS
(b)
X
S
S
(c)
X
S
CO2Me
NHFmoc
S
X=O,S
Scheme D.8. Alternative synthetic route toward compound 4-1 involving a
[2+2+2] cycloaddition strategy. (a) i) n-BuLi, THF, −78 ◦C, ii) S8, iii) Im2CO
or Im2CS; (b) i) TBAF, THF; (c) i) RuCl(PPh3)3, EtOH, ii) l-Fmoc-Prg-OMe.
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